250-403 Related Links

250-403 Killexams-Blog  |   250-403 Blogspot  |   250-403 Dropmark-Text  |   250-403 RSS Feed  |   250-403 ge.tt  |   250-403 4shared PDF  |   250-403 files.fm   |   250-403 4shared  |   250-403 coursehero.com  |   250-403 ello.co  |   250-403 clipsharelive.com   |   250-403 blogdigy.com  |   250-403 Youtube  |   250-403 sites.google.com  |   250-403 justpaste.it/  |   250-403 Instapaper  |   250-403 spaces.hightail.com  |  
Pass4sure 250-403 Actual Questions are best to Pass 250-403 Cert. - Killexams

Shortest question are protected in 250-403 question bank.

250-403 Dumps | 250-403 Exam Questions | 250-403 brain dumps | 250-403 test questions | 250-403 cbt - Killexams.com



250-403 - Administration of Symantec(TM) Management Platform 7.1 - Dump Information

Vendor : Symantec
Exam Code : 250-403
Exam Name : Administration of Symantec(TM) Management Platform 7.1
Questions and Answers : 174 Q & A
Updated On : Click to Check Update
PDF Download Mirror : 250-403 Brain Dump
Get Full Version : Pass4sure 250-403 Full Version


Where should I search to get 250-403 actual test questions?

Here's but every different vote for Killexams because of the Great manner to put together for 250-403 exam. I opted for this kit to prepare for my 250-403 exam. I did not set my hopes too immoderate and stored an eye-fixed constant on the reputable syllabus to make sure I do not pass over any topics, and it has become out that Killexams had all of them protected. The guidance became very strong and that I felt assured on the exam day. And what virtually made Killexams fantastic emerge was the moment when I found out their questions had been precisely similar to what real exam had. as promised (which I did not assume to be right - you recognize the way it works once in a while!). So, this is extraordinary. do not hesitate, cross for it.

Dont forget to try these dumps questions for 250-403 exam.

Thumb up for the 250-403 contents and engine. correctly worth buying. Absolute confidence, referring to my pals

No questions became asked that turned into now not in my Q&A manual.

I never concept I must pass the 250-403 exam. But I am 100% sure that without Killexams I have not accomplished it very well. The impressive Questions and Answers dump provides me the wished capability to take the exam. Being familiar with the supplied dump I passed my exam with 90 two%. I never scored this a lousy lot mark in any exam. It correctly idea out, effective, and reliable to use. Thanks for presenting a dynamic dump for the knowledge.

Found an authentic source for real 250-403 exam questions.

It changed into a very brief choice to have Killexams braindumps as my test associate for 250-403. I could not manage my happiness as I began seeing the questions about the screen; they have been like copied questions from Killexams dumps, so correct. This helped me to pass with 97% within 65 mins into the exam.

where am i able to locate loose 250-403 examination dumps and questions?

The Dumps supplied with the help of the Killexams were surely a few elements great. However, I secured 92% marks within the real 250-403 exam. All credit score marks go to you people most effective. It is difficult to assume that if I used another product for my exam. It is difficult to get a great product like this ever. Thank you for the whole lot you provided to me. I can honestly suggest it to all.

Prepare 250-403 Questions and Answers otherwise Be prepared to fail.

I bought 250-403 dumps on the internet and discovered Killexams. It gave me several cool stuff to test for my 250-403 exam. I was able to get via the test without issues. 250-403 exam questions and answers with the VCE exam simulator are quite cool stuff. Just memorizing is required.

Need to-the-point knowledge of 250-403 topics!

Never suspected that the issues that I had dependably fled from could be such an outstanding quantity of enjoyable to test; its simple and short method for purchasing to the focuses made my planning component much less disturbing and help me in getting 89% marks. All due to Killexams dumps, I concept I would pass my exam but I did finish decisively. I turned into going to give up exam 250-403 when you consider that I was not wondering about whether I could pass or no longer. With virtually every week staying I chose to interchange to Dumps for my exam-making plans.

real check 250-403 Questions and solutions.

Each subject matter and vicinity, each state of affairs, Killexams 250-403 materials have been exquisite help for me even as getting ready for this exam and doing it! I used to be anxious, but going again to this 250-403 Questions and Answers and questioning that I know the whole lot due to the fact the 250-403 exam was very clean after the Killexams stuff, I got an excellent result. Now, doing the following degree of 250-403 certifications.

amazed to look 250-403 dumps and examine guide!

Killexams become a blessing for 250-403 exam, cause that gadget has a lot of tiny info and configuration tricks, which will be tough if you do not have a bit of 250-403 experience. Killexams 250-403 questions and answers are enough to sit down and pass the 250-403 exam.

these 250-403 questions and answers provide proper expertise of subjects.

I passed both the 250-403 first try itself with 80% and 73% resp. Thanks a lot for your help. The question bank helped. I am thankful to Killexams for helping a lot with so many papers with answers to work on if not understood. They were extremely useful. Thank you.

See more Symantec dumps

ST0-173 | ST0-174 | 250-410 | ST0-085 | 250-255 | ST0-192 | 250-251 | 850-001 | ST0-155 | 250-530 | ST0-149 | 250-406 | 250-352 | ST0-200 | 250-403 | 250-254 | 250-370 | 250-407 | 250-310 | ST0-153 | 250-315 | 250-411 | 250-271 | ST0-134 | 250-316 | ST0-306 | ST0-247 | ST0-130 | 250-428 | ST0-303 | 250-270 | 250-371 | 250-311 | 250-513 | ST0-248 | ST0-304 | 250-253 | ST0-135 | 200-309 | ST0-250 | ST0-172 | 250-412 | ST0-147 | 250-250 | 250-314 | 250-318 | ST0-237 | ST0-148 | ST0-202 | 250-512 |

Latest Exams added on Killexams

ACT-English study tools | ACT-Math pdf study guide | SBAC blog | CPP-CPA official cert guide library pdf | DCPP-01 online tyari | JN0-221 Sample Test | 050-733 exam tips | PMI-PBA free ebook | EX407 q and a questions | Salesforce-Certified-CPQ-Specialist official cert guide library pdf | Servicenow-CIS-ITSM free pdf | VCS-260 latest dumps | VCS-261 frame relay | VCS-278 MCQ | VCS-325 study help | ACCP-v6.5 pdf study guide | 1V0-41.20 exam answers | NSE6_FWB-5.6.0 sybex | NSE5_FMG-6.4 test prep online | ASM dumps pdf | SC-400 is hard | MB-920 boson practice | MB-800 passleader | PL-600 tutorial | AZ-600 download | SC-300 blog | SOA-C02 training tips | SC-200 exam questions & answers | 5V0-21.20 quiz questions | NS0-171 pdf study guide | 3V0-42.20 academic edition | HPE6-A72 pass4sure download | 2V0-21.21 practice questions | HPE6-A73 kickass | NSE4_FGT-6.4 examcollection | C1000-083 Question Bank | HPE6-A82 ebook | NS0-161 official cert guide pdf | NS0-183 blog | DP-203 camp | C1000-100 updated questions | JN0-362 passcertification | JN0-412 questions and answers | JN0-681 download | JN0-635 free test engine | SPLK-2001 braindump | GPYC free answers | MB-910 exambraindumps | PCCET free pdf | Google-PCE exam prep | PCAP-31-03 actual test pdf | JN0-663 camp | DAS-C01 network simulator | JN0-553 study tools | CS0-002 visual cert exam | 312-50v11 passguide | EXIN-ITILF free ebook | Google-IQ study material | GMAT-Quntitative certkingdom | 1Y0-312 official cert guide library | 2V0-21.19D elearningexams | 2V0-31.20 camp | 2V0-41.20 exam collection | ACLS certkingdom | AI-900 questions & answers with explanations | ASTQB-CMT official cert guide library pdf | C2070-987 troytec | C2070-994 discounted sale | C2090-558 updated questions | CFA-Level-II exam time | CLSSMBB testinside | GMAT-Verbal test prep online | LSAT-Logical-Reasoning free pdf | LSAT-reading-comprehension official cert guide library | MB-500 pdf | Scrum-Master-Certified free e-book | SPLK-3003 study help | 300-515 test prep online | 300-915 visual cert exam | 1Y0-403 mock exam | SY0-601 online test | DES-1241 Sample Test Questions | DES-1D12 syllabus | DEA-5TT1 Sample exam | FML-5.3.8 exam papers | NSE8-811 exam fee | HPE2-E72 testking pdf | HPE0-S47 dumps in pdf | C1000-010 exam tips | ATA exam questions & answers | PL-100 q and a questions | PL-200 study help | PL-400 pass-guide | OG0-061 sybex | VMCE2020 examcollection | 5V0-33.19 book pdf | 5V0-34.19 study island | C1000-019 number of questions | C1000-022 answers | C9510-052 getfreedumps | HP2-H88 passing score | HP2-N49 testinside | HP2-Z36 sam learning | HPE0-S57 pass4sure | HPE6-A27 lab workbook | P9560-043 elearningexams | 100-490 exam cost | 143-085 exam | 143-425 made easy | 150-130 free pdf | 150-820 premium vce file | 170-010 exam questions & answers | 200-201 Sample exam | 200-901 study guide | 2V0-21.20 book download | 2V0-61.20 examcollections | 300-535 free download | 300-710 accurate answers | 300-715 free download | 300-720 exam time | 300-725 free ebook | 300-730 questions answers pdf | 300-735 training tools | 300-820 pdf download | 300-835 exam collection | 500-440 frame relay | 600-660 blueprint | 75940X accurate answers | 76940X free pdf | AD0-E308 blueprint | AZ-104 free test engine | AZ-303 dumps pdf | AZ-304 notes | CFR-310 tutorial | CCSK exam objectives | CTFL-2018 syllabus | CV1-003 questions and answers pdf | CWNA-108 practice questions | DA-100 exam prep | DES-5121 exam guide | DES-5221 results | DP-300 test prep | DP-900 exam engine | EADA105 testinside | EADE105 answers | IAPP-CIPM kaplan test | IAPP-CIPP-E Answers Bank | IIBA-AAC online test | iSAQB-CPSA-F examcollection | JN0-103 by examtut | JN0-334 questions & answers | JN0-648 passleader | Magento-Certified-Professional-Cloud-Developer is percent of | MCPA-Level-1 dumps pdf | MO-201 exambraindumps | MS-203 test prep | MS-600 quick reference | NS0-193 answers | NS0-591 Sample Question and Answer | NSE4_FGT-6.2 exam voucher | NSE5_FMG-6.0 home lab | NSE7_SAC-6 correct answers | Nutanix-NCP recommended book | PEGAPCSSA80V1_2019 practice test | SAA-C02 pass4sure download | Salesforce.Field-Service-Lightning-Consultant ebook | SPLK-1002 studies | 2V0-21-19-PSE made easy | SPLK-3001 flash cards | CSBA pass-guide | Servicenow-PR000370 actual test | Servicenow-CIS-VR free ebook | Servicenow-CIS-SAM accurate answers | Servicenow-CIS-RC accurate questions | Servicenow-CIS-ITSM exam cost | Servicenow-CIS-HR elearningexams | Servicenow-CIS-EM vce download | Servicenow-CIS-CSM amazon | Servicenow-CAD mock exam | Scrum-PSM-II dumps pdf | Salesforce-Certified-Sales-Cloud-Consultant is percent of | Salesforce-Certified-Marketing-Cloud-Email-Specialist passleader | Salesforce-Certified-Marketing-Cloud-Consultant questions answers pdf | Salesforce-Certified-Identity-and-Access-Management-Designer passing skills | Salesforce-Certified-Community-Cloud-Consultant questions answers pdf | Salesforce-Certified-B2C-Commerce-Developer bootcamp | Salesforce-Certified-Advanced-Administrator aio testking | QSSA2018 training tips | PEGAPCRSA80V1_2019 exam dumps | PEGAPCDC80V1 free test engine | MCIA-Level-1 | MCD-ASSOC test questions | ASVAB-Assembling-Objects material pdf | ASVAB-Paragraph-comp exam questions & answers | ASVAB-General-Science notes | ASVAB-Mathematics-Knowledge exam success | ASVAB-Electronic-Info sam learning | ASVAB-Automotive-and-Shop book download | ASVAB-Mechanical-Comp pass4sure | ASVAB-Arithmetic-Reasoning notes | ASVAB-Word-Knowledge Question Bank | MB-901 prometric exam | MB-700 official certification guide | MB-600 correct answers | MB-400 mock exam | AZ-220 passing skills | AZ-120 vce download | Magento-2-CAD academy | 701-100 Sample Test Questions | 101-500 pearson vue | ITIL-Practitioner download | C1000-026 ebook | C1000-012 real-exams | C1000-003 lab questions | C1000-002 exam time | IAPP-CIPT actual test | HPE2-W05 quick reference | HPE2-T35 Sample Test | HPE2-E70 vce exam simulator | HPE2-CP02 discounted sale | HPE0-V14 pass score | HPE0-S58 aio downloader | NSE7_EFW-6.2 number of questions | NSE7_ATP-2.5 download | 212-89 kickass | CAU201 training videos | 1Y0-204 accurate answers | AD0-E301 dumps pdf | TB0-123 practice quiz | WorkKeys exam questions & answers | TEAS-V6 home lab | SCS-C01 pass score | RPFT test inside | PL-900 q and a questions | MS-700 free ebook | HESI-A2 how many questions | Google-AVA training videos | Google-ASA testinside | Google-AMA kit | GCED practice test | GASF examsokay | CRT-450 test questions | CRT-251 practice quiz | CRT-160 exambraindumps | CLTD study island | CCRA sam learning | AZ-204 downloads | AZ-202 testking | ASSET exam collection | ACE-A1.2 passleader | AACD kindle | 98-388 lab manual | PCNSE-PANOS-9 practice quiz | NSE7_EFW-6.0 aio downloader | 200-301 practice questions | Watchguard-Essentials actual test pdf | TCRN network simulator | T1-GR1 ebook | SVC-19A lab kit | SPLK-2002 study guide | SPLK-1001 sybex pdf | RE18 free pdf | RACP Answers Bank | QSDA2018 pdf study guide | QSBA2018 vce files | PEGACRSA80V1 dumps pdf | PEGACPDC74V1 aio testking | PCNSA book pdf | PCCSA amazon | NRP dumps free download pdf | NLN-PAX training tools | NCC quiz questions | NAB-NHA Answers Bank | Mulesoft-CD premium vce file | MLS-C01 cheat sheet pdf | LFCS testinside | HPE6-A71 free download | HPE6-A70 braindump | HPE6-A68 questions & answers | HPE6-A67 guide | HPE6-A49 sparknotes | HPE6-A48 Sample exam | H31-611 official cert guide | Gsuite updated questions | Google-PDE free answers | Google-PCSE pdf-archive | Google-PCNE free pdf | Google-PCD braindump | FSLCC dumps free download pdf | ECSAv10 practice test | DVA-C01 mock | DP-201 troytec | DOP-C01 pass4sure download | DEV-450 ebook download | DES-6332 study guide pdf | DES-6321 aio testking | DES-4421 questions and answers | DES-1423 blog | DEA-1TT4 studies | CWT-100 cert guide | CWDP-303 objectives | CSLE free answers | CLO-002 kaplan test | CLF-C01 certification guide | CIMAPRO17-BA2-X1-ENG dumps pdf | CIMAPRO15-E03-X1-ENG Sample exam | CHAD ebook | CCSP sybex | CBSA pdf | CBDH discounted sale | CBDE test engine | CBBF difficulty | CAMS exam leader | C2040-986 downloads | BDS-C00 actual test | AWS-CDBS online test | AWS-CASBS study | ARA01 exam dumps | APSCA pass-guide | APD01 flashcards pdf | ANS-C00 accurate test | AI-100 pdf download | AD0-E452 questions & answers | AD0-E106 study island | AD0-E104 lab kit | AD0-E103 premium vce file | AD0-E102 Sample Test Questions | AD0-300 updated questions | AD01 training tips | ACSCE-5X examsokay | ACP-600 exam prep | ACP-100 amazon | ACA-Cloud1 visual cert exam | ABPN-VNE simulator download | ABFM pass4sure dumps | ABCTE real-exams | 9A0-412 how many questions | 840-450 MCQ | 77-727 study guide pdf | 77-725 objectives | 5V0-62.19 vce free | 5V0-61.19 braindump | 5V0-21.19 pass tips | 500-215 free ebook | 4A0-M05 ebook | 4A0-C01 Question Bank | 350-901 guaranteed success | 350-801 cert guide | 350-701 questions & answers | 350-601 premium vce file | 350-501 pass-guide | 350-401 test inside | 300-920 testking pdf | 300-910 kaplan test | 300-815 real-exams | 300-810 actualtests | 300-635 frame relay | 300-625 Sample Questions | 300-620 Sample Test Questions | 300-615 practice questions | 300-610 best study techniques | 300-510 questions and answers | 300-435 actual test pdf | 300-430 vce files | 300-425 getfreedumps | 300-420 cert guide | 300-415 testking | 300-410 study guide | 2V0-41.19 premium vce file | 2V0-31.19 sparknotes | MS-500 MCQ | TMSTE downloads | ServiceNow-CSA free dumps | SDM_2002001050 practice test | PEGACSSA74V1 network simulator | NS0-002 exam prep | JN0-348 is percent of | ITIL-4-FOUNDATION dumps pdf | CCCP-001 examsokay | AZ-500 questions and answers | ANVE exam objectives | 50-695 pearson vue | 3M00030A official cert guide | 2V0-51-19 free dumps | 1Y0-440 official cert guide library pdf | 102-500 number of questions | SIAMF frame relay | QV12BA practice quiz | PSM-I exam guide | PR000005 study guide | Platform-App-Builder discounted sale | PDII by examtut | PCIP3-0 free answers | MB-330 actualtests | MB-300 guaranteed success | MB-220 visual cert exam | HPE0-J50 pass-guide | H19-301 lab kit | Google-ACE exam | DES-9131 questions answers pdf | DES-2T13 quick reference | DES-1B31 best study techniques | CTFL-Foundation download | C1000-004 aio testking | 700-751 dumps in pdf | 5V0-32-19 training tips | 4A0-N02 online test | 2V0-61-19 passing skills | 050-6201-ARCHERASC01 exambraindumps | XK0-004 official cert guide pdf | SPLK-1003 exam dumps | PSAT-RW training tools | P2090-095 pdf | MS-900 exam objectives | MB-320 academy | MB-310 testking | MB-240 braindump | MB-230 study guide pdf | MB-210 dumps in pdf | HPE0-S56 quick reference | HPE0-S55 syllabus pdf | H19-307 exam questions & answers | GRE-Verbal passing skills | GRE-Quantitative free dumps | C4040-100 actual test | C2090-616 simulation questions | 78200X guide | 2V0-21-19D aio downloader | 250-440 pdf-archive | HPE2-E71 camp | PEGAPCSA80V1_2019 pdf download | PEGACPMC74V1 practice questions | PEGACPBA74V1 | NS0-509 exam dumps | NS0-182 is hard | NS0-160 is hard | MB-200 real-exams | HPE2-CP04 nbcot exam prep | HPE0-S54 bootcamp | HPE0-S50 test inside | H13-523 ebook download | DP-200 kindle | DES-3611 test engine | DCA lab questions | CTFL_Syll2018 sparknotes | AZ-103 correct answers | 830-01 | 700-651 free dumps | 700-150 free pdf | 500-230 is hard | 4A0-N01 aio testking | 352-011 sybex | 2V0-21-19 syllabus | TTA1 examcollection | PEGACSA74V1 Sample Question and Answer | NS0-300 exam tricks | MS-101 exam questions & answers | JN0-220 pdf-archive | HPE2-W02 simulator | HP2-H84 actual test | HP2-H80 pdf download | HP2-H78 sybex | E20-893 prometric exam | DES-1B21 cheat sheet pdf | ATTA nbcot exam prep | ATM test questions | 5V0-31-19 official cert guide pdf | 2V0-602PSE troytec | 2V0-51-18 aio testking | 2V0-01-19 sybex | 156-315-80 free test engine | 010-160 academic edition | SVC-16A passcertification | PRINCE2-Re-Registration lab kit | NSE8-810 training videos | NSE5_FAZ-6-0 pdf | MS-301 studies | MS-300 testking pdf | MS-201 network simulator | MS-200 guide | MS-100 exambraindumps | MD-101 exam cram | MD-100 test questions | MAC-16A practice test | MA0-107 Sample exam | JN0-1101 questions and answers pdf | HPE0-J58 dumps pdf | H31-523 download | H31-211 practice questions | H13-629 accurate test | H13-612 download | H13-611 training videos | H13-511 cert guide | H12-711 Sample Questions | H12-311 test-king | H12-223 blog | H12-222 Sample Test | Google-PCA quiz questions | FC0-U61 exam time | DP-100 free book | DES-4121 pass tips | DEE-1421 made easy | DEA-2TT3 elearningexams | CWAP-403 passguide | CCE-CCC book download | CAU302 quick reference | C2150-610 free e-book | C2090-101 pdf download | AZ-900 bootcamp | AZ-400 by examtut | AZ-203 flashcards pdf | AWS-CSS dump | AWS-CSAP pdf study guide | AWS-CSAA-2019 certkingdom | 7495X sybex pdf | 7492X material pdf | 7392X pass4sure | 72200X MCQ | 71200X questions answers pdf | 500-901 examsking | 500-470 testking | 3V0-752 free book | 3V0-732 testking pdf | 312-50v10 testinside | 2V0-622PSE correct answers | 2V0-01.19 pass4sure download | 250-437 actual test | 220-1002 syllabus pdf | 220-1001 lab kit | 156-115.80 exam answers | 500-490 study guide pdf | NSE4_FGT-6-0 pdf | PCAP-31-02 certificationking | JN0-1301 exam questions & answers | HPE6-A07 free e-book | HPE0-J55 braindump | DEA-64T1 guaranteed success | DEA-41T1 syllabus | CCSPA number of questions | CAU301 testinside | 7497X free pdf | 3V00290A free book | 3314 pdf download | 3313 exam cost | 3312 transcender | 250-441 training videos | 156-727-77 training tools | PEGACPBA73V1 dumps pdf | NS0-513 kit | NS0-181 study guide | NS0-159 dumps | ML0-320 examsokay | MB6-898 examsking | JN0-662 MCQ | HPE6-A47 Sample Test | HPE0-J57 exam cram | HP2-H67 guide | HP2-H65 case study | FortiSandbox study guide | AZ-301 objectives | AZ-300 difficulty | A2040-918 syllabus pdf | 1Y0-340 simulation questions | WPT-R exam cost | WHNP nbcot exam prep | VACC study guide pdf | TEAS-N mock | RDN passguide | PET Answers Bank | PCCN best study techniques | PCCE vce download | PANRE exam cram | PACE test questions | OCS exam prep | NSCA-CPT updated questions | NREMT-PTE home lab | NREMT-NRP blog | NRA-FPM exam engine | NNAAP-NA testking pdf | NE-BC trainsignal | NCPT nbcot exam prep | NCMA-CMA made easy | NCIDQ-CID simulation questions | NCEES-PE aio downloader | NCEES-FE vce files | NCCT-TSC official cert guide library pdf | NCCT-ICS practice questions | NBDE-II pass score | NBDE-I questions and answers | NBCC-NCC transcender | NAPLEX camp | MSNCB free book | MHAP exam voucher | LCDC training tools | LCAC answers | IFSEA-CFM actual test | IBCLC exam papers | GPTS mock | FSMC guaranteed success | FNS updated questions | ESPA-EST ebook | DTR mock exam | DSST-HRM testking | CBCP full version | DHORT exam time | DAT pass4sure dumps | CVPM ebook | CRNE dumps pdf | CPM sparknotes | CPCE Question Bank | COMLEX-USA aio downloader | CNSC certificationking | CGRN test-king | CFSW lab workbook | CDM sam learning | CDCA-ADEX exam questions & answers | CCP Question Answer Bank | CCN free ebook | CCI exambraindumps | BMAT lab questions | BCNS-CNS guide | AXELOS-MSP cheat sheets | APMLE exam answers | ANP-BC cert guide | ANCC-MSN accurate questions | ANCC-CVNC exam answers | AHIMA-CCS practice questions | AEMT guaranteed success | ACSM-GEI vce download | ACNP flashcards pdf | ACF-CCP exam objectives | ABEM-EMC Sample Questions | AAMA-CMA examcollection | AACN-CMC free dumps | CPA-AUD self test | CPA-REG accurate test | PT0-001 q and a questions | DES-1721 free pdf | CV0-002 pearson vue | C9560-517 getfreedumps | C9550-413 actualtests | C5050-380 Question Bank | C2210-422 pdf-archive | C2010-530 correct answers | 9A0-411 ebook | 98-383 Quiz | 70-537 passleader | 500-325 academic edition | 202-450 camp | VCS-316 Sample Question and Answer | NCIDQ training videos | MBLEX braindump | LEED-GA actualtests | IAHCSMM-CRCST accurate questions | HQT-4210 recommended book | HPE6-A42 free test engine | HP2-H62 passcertification | HCE-5420 study island | E20-575 testking | NBSTSA-CST sybex | CDCS-001 is hard | C5050-384 free download | C2070-582 official cert guide library | C2010-825 pdf | A2040-921 pearson vue | A2040-910 ebook | 7765X Answers Bank | 700-901 premium vce file | 700-551 lab kit | 250-430 full version | 1Y0-402 official cert guide library | 1D0-621 kickass | 156-215-80 made easy | HPE0-S48 study material | JN0-410 study guide | C2090-735 pdf download | C2090-603 exam cost | 7241X examsking | 7141X pass4sure download | 700-105 home lab | 500-710 Sample Questions | 200-401 online tyari | 090-077 study guide pdf | VCS-256 Question Bank | HPE2-T34 test engine | HPE2-K43 downloads | HCE-5710 prometric exam | E20-585 tutorial | CAS-003 actual test | 9A0-410 study guide | 98-382 academic edition | 98-381 pass4sure dumps | 810-440 syllabus | 700-265 pass guarantee | 700-020 exam prep | 70-779 blueprint | 70-745 test inside | 500-551 pass4sure dumps | 500-301 exam success | 3V0-624 free ebook | 300-100 network simulator | 156-915-80 amazon | VCS-413 exam tips | VCS-275 download | VCS-274 trainsignal | PCNSE free pdf | N10-007 free dumps | MB6-897 kaplan test | ITEC-Massage free answers | HPE2-E69 trainsignal | HPE2-E55 braindump | HPE0-S52 pearson vue | HPE0-J78 new questions | FTCE exam objectives | Firefighter questions and answers | CSWIP cheat sheet pdf | CPT aio downloader | APA-CPP academic edition | CPFA cert guide | CPAT examsking | CCC latest dumps | CAT-340 test prep online | IAAP-CAP pdf study guide | C2150-609 examcollections | C2090-320 practice test | BCB-Analyst camp | 7491X questions & answers | 7391X network simulator | 70-705 pass guarantee | 500-701 aio downloader | 500-651 free book | 201-450 cheat sheet | 1V0-701 free pdf | ACMA-6.4 passing score | ACMA-6.3 frame relay | VCS-257 tutorial | SPHR download | SDM-2002001040 prometric exam | SDM-2002001030 material pdf | S10-110 answers | PEGACLSA_6.2V2 difficulty | PDM-2002001060 examcollection | PCAT exam cram | P2090-027 training tools | NSE4-5-4 how many questions | NCS-20022101010 exam questions & answers | NCLEX-RN accurate test | NCLEX-PN blueprint | MB6-894 how many questions | JN0-411 official cert guide library | JN0-361 book pdf | ITILFND free answers | IIA-CIA-Part3 free dumps | IIA-CIA-Part2 pass tips | IIA-CIA-Part1 pass tips | HPE6-A45 sam learning | HPE6-A43 sam learning | HPE2-Z40 online tyari | HPE0-S51 exam cost | HP2-B129 official cert guide library pdf | Hadoop-PR000007 training tips | H12-261 exam time | FCNSP.V5 syllabus | E20-920 pass tips | E20-307 questions and answers | DEV-401 best study techniques | CWNA-107 ebook download | CTAL-TM_Syll2012 free e-book | CTAL-TA_Syll2012 questions & answers with explanations | CPIM-MPR visual cert exam | CPD-001 accurate questions | CoreSpringV3.2 free answers | C9530-519 exam guide | C9060-528 network simulator | C9060-521 new questions | C9030-644 training tips | C9020-667 exam prep | C9020-662 download | C2180-275 Sample Test | C2180-273 getfreedumps | C2150-630 pass tips | C2140-823 pdf | C2090-623 exam collection | C2070-588 exam papers | C2070-586 discounted sale | C2070-585 simulator download | BAGUILD-CBA-LVL1-100 Question Bank | 70-778 pass guarantee | 70-768 exam pdf | 70-767 notes | 600-211 bootcamp | 600-210 answers | 412-79v8 exam answers | 3203 passguide | 312-49v9 pass tricks | 3101 exam tips | 3100 questions and answers pdf | 2D00056A test questions | 1Y0-203 premium vce file | 156-915.77 case study | 156-727.77 passing skills | 156-315.77 download | 156-315.65 boson practice | 156-215.65 pdf download | 156-115.77 training tips | 050-v5x-CAARCHER01 download | 050-80-CASECURID01 Quiz | 002-ARXTroubleshoot flashcards pdf | SY0-501 practice test | VCS-323 training tips | VCS-322 exam cram | T7 by examtut | NS0-505 made easy | M9550-752 pearson vue | JN0-647 dumps pdf | JN0-634 examcollection | JN0-347 official certification guide | JN0-333 boot camp | HPE6-A44 pdf download | FAR accurate questions | DES-1D11 pass4sure download | CEMAP-1 is percent of | C9560-515 accurate questions | C9560-040 number of questions | C9530-001 study guide | C9510-418 premium vce file | C9050-041 questions answers pdf | C9020-668 testking pdf | C9020-563 practice test | C8 exam cram | C2150-620 pass guarantee | ADM211 dumps pdf | 9A0-383 full version | 7691X new questions | 7595X exam guide | 6210 exam engine | 250-428 exam leader | 200-710 sparknotes | 1Y0-311 examcollections | 1Y0-240 exam cost | 1Y0-230 aio downloader | 156-215-77 download | 412-79v9 new topics | IELTS pearson vue | VCS-412 exam fee | VCS-409 cert guide | VCS-371 pass4sure download | VCS-352 free answers | VCS-319 boson practice | VCS-318 questions & answers | VCS-310 quick reference | VCS-277 dump | VCS-276 Sample Question and Answer | VCS-271 frame relay | VCS-255 questions answers pdf | VCS-253 passleader | VCS-252 made easy | VCS-220 exam success | S10-210 questions and answers | PPM-001 flash cards | PK0-004 exam guide | NS0-507 academic edition | NS0-506 simulation questions | NS0-191 download | NS0-180 exam engine | NS0-158 Sample Test | LCP-001 Sample Questions | JN0-680 certification guide | HPE6-A41 study island | HPE6-A29 aio downloader | HPE6-A15 sybex pdf | HPE2-Z39 Answers Bank | HPE2-T27 pdf download | HPE0-S22 practice questions | HPE0-J80 questions and answers pdf | HPE0-J79 dumps in pdf | HP2-Z34 pass tricks | HP2-H32 made easy | HP2-B149 camp | HP2-B148 questions & answers | HP2-B144 free download | HC-224 pass score | H12-211 tutorial | E20-375 study guide | C9520-421 real-exams | C9060-511 study tools | C5050-300 actual test | BEC accurate test | AHM-540 guaranteed success | A2090-719 training tips | 9A0-803 download | 9A0-702 amazon | 9A0-602 Question Bank | 9A0-394 study help | 9A0-392 study material | 9A0-382 practice questions | 9A0-045 simulation questions | 98-368 free dumps | 7591X nbcot exam prep | 700-802 vce free | 700-295 academic edition | 70-744 study material | 70-357 practice test | 62-193 pass4sure download | 501-01 new questions | 500-290 study guide | 500-265 test questions | 303-200 questions answers pdf | 2V0-642 vce exam simulator | 2U00210A free book | HPE0-S46 official answers | HPE0-S37 academic edition | HPE0-J77 network simulator | HPE0-J76 exam questions & answers | HPE0-J75 lab kit | CWAP-402 lab questions | C2090-625 lab workbook | 9A0-367 syllabus pdf | 7693X book download | 7593X study guide | 70-764 download | 500-052 exam voucher | MA0-103 kit | JN0-1100 notes | HPE2-Z38 examcollections | E20-526 self test | CS0-001 prometric exam | 9A0-381 questions & answers with explanations | 7750X actual test | 7304 pass4sure | 70-742 camp | 156-730 flashcards pdf | MB2-716 updated questions | HPE2-W01 test engine | HPE2-E68 testking pdf | HPE2-E67 killtest | 9A0-395 pass-guide | 9A0-393 dumps pdf | 70-741 recommended book | 210-255 questions & answers | NSE8 certificationking | HPE2-T22 exam cost | FSDEV training tools | C9520-403 material pdf | C9510-669 questions & answers with explanations | C2150-463 pdf download | C2090-621 q and a questions | C2090-600 full version | 7230X study help | 7220X exam time | 7130X questions & answers | 70-740 updated questions | 202-400 free ebook | 201-400 exam questions & answers | P5050-031 exam | OMG-OCRES-A300 exam questions & answers | NSE6 home lab | MA0-104 exam tips | JN0-661 MCQ | JN0-346 pass4sure dumps | JN0-1330 by examtut | E20-624 updated questions | E20-562 sam learning | CPIM-BSP notes | C9520-929 simulation questions | C9520-928 mock | C9520-923 questions answers pdf | C9520-911 difficulty | C9510-819 test questions | C9050-549 exam | C9050-548 free pdf | C9050-042 exam engine | C9010-262 exam pdf | C2090-136 objectives | C2010-555 case study | 9A0-409 guaranteed success | 70-765 syllabus | 500-210 Sample Questions | 500-205 exam objectives | 210-250 by examtut | PEGACSA72V1 test inside | M2150-756 Sample Question and Answer | JN0-1300 sparknotes | HPE2-T30 download | C9560-574 simulator download | C9560-568 blog | C9560-507 study guide pdf | C9560-505 made easy | C9560-503 full version | C9550-605 cert guide | C9520-423 flashcards pdf | C9010-250 sparknotes | C8060-220 exam questions & answers | C5050-287 questions & answers | ASVAB exam questions & answers | 7893X vce exam simulator | 70-762 syllabus pdf | 70-761 discounted sale | 70-743 pdf download | 70-339 blog | 600-455 Question Bank | 3C00120A nbcot exam prep | TM12 q and a questions | TA12 exam questions & answers | PR000007 flash cards | P9510-020 Sample Questions | P9050-005 | P8060-002 aio testking | P8060-001 accurate answers | P8010-088 exam objectives | P8010-034 dump | P8010-005 exam leader | P8010-004 pass guarantee | P6040-025 by examtut | P6040-017 certificationking | P2180-089 cheat sheets | P2170-035 mock exam | P2170-033 recommended book | P2140-022 Answers Bank | P2140-020 certification guide | P2090-086 Sample Question and Answer | P2090-080 blog | P2090-076 premium vce file | P2090-068 exam answers | P2090-046 home lab | P2090-045 free e-book | P2090-011 exam papers | P2090-010 updated questions | P2070-072 testking | P2070-053 study tools | P2065-037 sparknotes | P2065-016 objectives | P2065-013 real-exams | P2050-028 getfreedumps | P2050-006 prometric exam | P2040-060 exam voucher | P2020-007 best study techniques | OG0-021 pass guarantee | NSE7 answers | MSC-331 study help | MSC-321 kit | M9560-760 dumps pdf | M9560-727 killtest | M9560-670 pearson vue | M9560-231 number of questions | M9510-726 dumps in pdf | M9510-664 bootcamp | M9510-648 Question Bank | M9060-719 Sample exam | M9060-616 pdf download | M8060-730 dumps pdf | M8060-655 guaranteed success | M8010-246 dumps pdf | M8010-241 exam tips | M8010-238 answers | M6040-520 testking | M6040-420 passing score | M6040-419 exam time | M2180-651 pdf study guide | M2140-726 exam | M2140-649 questions answers pdf | M2140-648 pearson vue | M2090-643 quick reference | M2090-618 notes | M2090-234 pass-guaranteed | M2080-663 actual test pdf | M2065-741 new topics | M2050-243 premium vce file | M2020-645 self test | M2020-620 tutorial | M2020-229 questions & answers | M2010-760 by examtut | M2010-719 troytec | ITILSC-OSA questions and answers | HP5-Z02D difficulty | HP5-H09D exam fee | HP5-H07D Sample Test | HP5-H03D how many questions | HP5-B05D questions & answers | HP2-N52 guaranteed success | HP2-N43 dumps in pdf | HP2-K41 is percent of | HP2-K39 test questions | HP2-H38 training videos | HP2-H37 cheat sheet pdf | HP2-H30 test questions | HP0-M74 actual test | HP0-M101 sybex pdf | HH0-350 pass-guide | C9560-510 test-king | C9550-400 pearson vue | C9060-518 aio downloader | C9010-030 free dumps | C7010-010 exam questions & answers | C2180-279 certificationking | C2180-183 exambraindumps | C2150-200 home lab | C2140-820 material pdf | A2040-951 number of questions | A2010-652 exam answers | A2010-572 results | 499-01 tutorial | Wonderlic lab kit | 250-412 online tyari | 250-411 study tools | 250-410 pass guarantee | 250-405 quiz questions | 250-272 academy | 250-254 answers | PEGACDA71V1 exam questions & answers | ACE vce exam simulator | 77-420 dumps in pdf | 70-345 study help | NCLEX online test | NBRC certkingdom | CNS passing skills | 304-200 boot camp | PCM study tools | P8010-003 free download | P2170-749 MCQ | P2170-037 discounted sale | P2170-036 getfreedumps | P2090-054 pass guarantee | P2080-088 quiz questions | P2080-034 answers | P2065-749 test engine | P2060-017 cheat sheet pdf | P2060-002 questions & answers | P2050-007 guide | P2050-005 quick reference | P2050-004 pass tricks | P2050-003 cheat sheets | M9510-747 quiz questions | M8060-729 pdf | M8010-242 elearningexams | M6040-427 pdf download | M5050-716 exam objectives | M2150-810 dump | M2150-753 ebook | M2150-728 exam objectives | M2090-732 home lab | M2090-626 sparknotes | M2090-615 bootcamp | M2080-713 practice questions | M2080-241 pass-guaranteed | M2065-659 dump | M2065-647 free book | M2050-655 exam objectives | M2050-242 blueprint | M2040-724 download | M2040-641 recommended book | M2035-725 pdf download | M2010-649 exam | M2010-616 braindump | C9560-658 actual test | C9560-023 exam cost | C9550-273 self test | C9530-404 download | C9520-427 passing skills | C9510-401 Questions Bank | C9510-317 free book | C9060-509 official cert guide pdf | C9030-634 passcertification | C9030-633 Sample Test | C9020-971 simulation questions | C9020-970 Sample Test | C9020-461 questions answers pdf | C9010-252 flash cards | C9010-022 actualtests | C8010-726 official cert guide pdf | C8010-725 studies | C8010-241 exam guide | C8010-240 trainsignal | C5050-285 academic edition | C5050-284 is hard | C5050-280 dumps pdf | C2180-410 download | C2150-508 quiz questions | C2090-930 pdf-archive | C2090-645 number of questions | C2090-642 exam cost | C2090-180 pass4sure dumps | C2090-013 objectives | C2090-011 exam pdf | C2040-985 training tips | C2040-958 vce download | C2010-940 questions and answers | C2010-654 questions answers pdf | C2010-653 aio downloader | C2010-517 exam fee | C2010-024 lab manual | BAS-004 examcollection | A6040-752 exam collection | A4120-784 is percent of | A2180-607 questions & answers | A2160-667 exam pdf | A2090-558 exam questions & answers | A2090-421 cert guide | A2040-986 vce free | A2040-913 download | A2040-441 notes | A2040-440 passguide | A2040-412 vce free | A2040-405 examcollection | A2040-403 aio downloader | A2010-599 real-exams | A2010-578 certkingdom | A2010-573 pdf download | A2010-564 test prep | A2010-538 full version | A2010-502 exam questions & answers | 000-198 exam guide | 000-052 network simulator | HP3-F18 answers | HP3-C36 prometric exam | HP3-C33 sparknotes | HP3-C29 vce download | HP2-H40 actual test pdf | HP2-H31 correct answers | HP0-Y52 new questions | HP0-M77 official cert guide pdf | HH0-380 exam | 106 study | E20-368 book pdf | SK0-004 number of questions | 1Y0-371 testking pdf | 700-703 pass4sure | CA-Real-Estate visual cert exam | AND-403 exam dumps | AND-402 free pdf | GED answers | 9A0-365 mock | 9A0-351 accurate questions | TEAS vce free | COMPASS amazon | PMI-002 pass-guaranteed | SSAT training videos | 70-333 bootcamp | QIA exam tips | Property-and-Casualty pass tips | PDDM study guide | PARCC pdf download | HH0-300 case study |

See more dumps on Killexams

SBAC | GE0-807 | 000-M99 | HPE2-Z40 | M2150-756 | P2050-003 | HP2-E60 | PCAP-31-03 | 090-077 | EADA10 | NYSTCE | 000-674 | LE0-406 | 201-450 | 310-016 | VCA410-DT | 190-982 | EADE105 | 1Y0-403 | JK0-U31 | 000-537 | HP2-B99 | HP5-B05D | HPE0-S47 | AD0-E301 | VCS-256 | A2010-565 | 1T6-521 | MB-330 | 3X0-201 | M8060-655 | 920-235 | CLSSGB | HD0-200 | C2010-657 | CBSA | JN0-334 | TEAS | DEA-64T1 | NS0-161 | 920-552 | NSE4-5-4 | HP3-C33 | OCS | CSTE | C2050-241 | HH0-530 | NSE7_EFW-6.2 | A2010-598 | CGEIT |

250-403 Questions and Answers

Pass4sure 250-403 Dumps with Real Questions & Practice Test


QUESTION: 164

Refer to the Exhibit.

image


In the scenario shown, directly assigned to the groups are the following numbers of computers: Southeast Asia - 10, Southwest Asia - 15, Asia - 37, and Headquarters - 120. If security is properly configured and an administrator is assigned management rights to the Southeast Asia group only, how many computers will they see at the world-wide administration level?


  1. 10

  2. 15

  3. 25

  4. 182


Answer: A


QUESTION: 165

Refer to the Exhibit.


image


What should the administrator choose to save a list of computers that can be used in a target?


  1. snapshot

  2. web part


  3. static filter

  4. spreadsheet


Answer: C


QUESTION: 166

Which rule must be followed when configuring a hierarchy?


  1. Each Notification Server must have one parent; each Notification Server must have one child.

  2. Each Notification Server can have zero or one parent; each Notification Server can have zero or more children.

  3. Each Notification Server can have zero or one parent; each Notification Server can have zero or one child.

  4. Each Notification Server can have zero or more parents; each Notification Server can have zero or one child.


Answer: B


QUESTION: 167

Which two Resource Attributes can be inherited from Base Resource Types? (Select two.)


  1. Association Types

  2. Resource Types

  3. Organizational Group

  4. Resource Scope

  5. Data Classes


Answer: A, E


QUESTION: 168

Which service must be configured on all Notification Servers to set up a hierarchy?


  1. Package

  2. OOB

  3. Task

  4. PXE


Answer: A


QUESTION: 169

Refer to the Exhibit.

image


An administrator has cloned the Windows x64 filter and wants to modify it to show unmanaged Windows x64 computers. Given the information provided in the exhibit, which action should the administrator perform to accomplish this task?


  1. in the "{0} Equals section" modify the [vComputerResource].[IsManaged] rule to read 0 instead of 1

  2. in the "{0} Equals section" add a [vComputerResource].[IsManaged] rule to read 0

  3. in the "{0} Equals section" add a [vComputerResource].[UnManaged] rule to read 1

  4. in the "{1} Like section" add an [AeX AC Identification].[System Type] expression of '%unmanaged%


Answer: A


QUESTION: 170

An administrator needs to review several Symantec Management Console reports daily and would like to have them in a single view. How can the reports be combined into a single view?


  1. create a custom dashboard that merges the reports

  2. create a custom portal page that displays each of the reports as web parts

  3. export the reports and import them into one custom folder

  4. link each of the reports to a single custom sub-menu item


Answer: B


QUESTION: 171

Refer to the Exhibit.

image


An administrator has cloned the Daily Event report. What must the administrator change to create a Weekly Event report?


  1. edit the Query Parameters to show a week of data

  2. edit the dateadd(day, -1, @cutoffdate) section

  3. edit the Resolved Query to show a week of data

  4. edit the views on the Views tab


Answer: B


QUESTION: 172

A policy can be applied to which item?


  1. filters

  2. targets

  3. organizational views

  4. organizational groups


Answer: B


QUESTION: 173

Several computer resources displayed within the Active Directory Organizational View were previously removed from Microsoft Active Directory organizational units. An Active Directory import is scheduled to run weekly. Which action can the administrator take to remove these computer resources automatically from the Configuration Management Database (CMDB)?


  1. create and enable an automation policy that removes these computer resources

  2. create a resource filter that contains these computers and delete them all at once from the filter


  3. enable the Directory Synchronization Schedule console option on the Active Directory Import page

  4. create and enable a server task to run a SQL query to remove the computer resources


Answer: C


QUESTION: 174

An IT management company contracts with other companies to manage their IT resources using the Symantec Management Platform. Their revenue is dependent on the number of resources they manage. What should the administrator do so that they will be immediately alerted when a new computer resource is discovered?


  1. create an automation policy based on the "New Computer Discovered" system message

  2. schedule the Update the All Computers Filter task to run every five minutes

  3. schedule the Discovered Computers report to refresh every five minutes

  4. add the administrator's address to the TO_EMAIL parameter in the New Machine automation policy


Answer: A


Symantec 250-403 Exam (Administration of Symantec(TM) Management Platform 7.1) Detailed Information

Train. Certify. Succeed!
Validate technical knowledge and competency by becoming a Symantec Certified Specialist (SCS) based on your specific area of Symantec technology expertise. To achieve this level of certification, candidates must pass one proctored SCS exam based on a combination of Symantec training material, commonly referenced product documentation, and real-world job scenarios.
Certification News
Find out what’s new in the Symantec Certification Program.
Prepare for an Exam
View the list of available exams and see the exam details and recommended preparation for each exam.
Learn about new item types on SCS exams.
Certification Process
Learn about the Certification Testing Process to find out how to register for exams and view exam fees.
Or, register for an exam now.
Certification Documents and Policies
Certification Documents and Policies
Learn about the Symantec Testing Policies and exam security protocols prior to taking your exam.
Manage Your Credentials
Manage Your Credentials
Log in to CertTracker to view exam progress and publish your credentials.
Subject Matter Expert Central
Register for notifications and/or to participate in our certification exam development process. Help design, write, or beta test the next generation of Symantec Certification Exams.
Read some frequently asked questions about Symantec Education Services and find out how to get additional help.
Why Get Certified?
Did you know that Symantec certifications ranked #1 as the top product vendor cyber security certifications by salary in the IT Security Salary Survey (Certification Magazine, November 2015) and that 76% of candidates and recruiters verified that Symantec Certification was discussed as part of the hiring process? Certification can open the door to increased visibility, better opportunities and new jobs in your industry. In today’s highly competitive environment, certification differentiates you as a professional who is serious about applied learning, making you an asset to a prospective employer. Read about the benefits of certification.
Symantec Training
We provide a number of training options to suit your schedule, budget and experience. Online eLearning courses are provided to you at no cost while Virtual Academy and classroom training are provided to you at a reduced cost.
Benefits
Gain a competitive edge
Close more business
Drive larger deals with improved knowledge
Smoother solution deployments
Differentiate yourself from the competition
Satisfy customer needs by selling the right solution
Achieve program membership status with access to more Partner Program benefits
Online eLearning
No cost eLearning that is available online exclusively to Symantec Partner Program members. Earning Symantec accreditations and authorizations may give you access to revenue enhancing and profitability programs. eLearning courses are organized into learning paths that prepare you to successfully complete the Symantec credentials:
Symantec Sales Expert (SSE)
Symantec Sales Expert Plus (SSE+)
Symantec Certified Specialist (SCS)
Virtual Academy
Online learning that recreates the traditional classroom experience via live webcasts, hands-on labs, on-demand modules and expert mentoring. Benefits include:
Less time out of the field
No travel costs
Attend any class in the world
Classroom training
Fee-based technical courses at Symantec locations around the world, offering the same content and in
What is the Symantec Certification Program?
The Symantec Certification Program provides rigorous, objective assessments of Symantec technical expertise through securely proctored, computer-based, multiple-choice exams (based on real-world job tasks). The program validates the skills and technical competencies necessary for Symantec professionals to efficiently implement, administer, and maintain their data protection, high availability, and security environments utilizing Symantec solutions.
Successful completion of the programs’ current requirements will result in the achievement and reward of either a Symantec Certified Specialist (SCS) or Symantec Certified Professional (SCP) certificate.
Who is the audience?
Symantec End Users, Customers, Employees, and Partners (optional). Although each product varies in complexity and depth, all certification exams are created specifically for customers and cover core elements measuring technical knowledge against factors such as installation, configuration, deployment, product management & administration, and day-to-day maintenance. While certification is optional for partners and employees, certification is not a requirement of the Symantec Partner Program and does not count toward program classification.
What is a Symantec Certified Specialist?
An End User, Customer, Employee, and/or Partner who has proven technical knowledge and competency by becoming Symantec certified based on their specific area of expertise with Symantec products.
What is a Symantec Certified Professional?
An End User, Customer, Employee, and/or Partner who has proven technical knowledge and competency by becoming Symantec certified based on their specific solution expertise with multiple Symantec products.
Is the Symantec Certification Program available worldwide?
Yes, it is a global certification program for IT professionals working with Symantec solutions worldwide.
What certifications are currently available?
Symantec offers Symantec Certified Specialist (SCS) and Symantec Certified Professional (SCP) certifications covering several different products and solutions by product versions. See more information on the currently available certifications.
Where can I find the individual certification requirements for each certification?
Certification requirements, sample exams, exam objectives, recommended training and registration is available for each certification and corresponding exam. Please click here for more information on Available Certifications.
What is the benefit of becoming Symantec Certified?
Symantec certified candidates and their companies have the ability to gain industry recognition, competitive differentiation, greater productivity & results, increased user community satisfaction, and a tangible measure of their education investment.
Did you know that 76% of candidates and recruiters verified that Symantec Certification was discussed as part of the hiring process? Certification can open the door to increased visibility, better opportunities and new jobs in your industry. In today’s highly competitive environment, certification differentiates you as a professional who is serious about applied learning, making you an asset to a prospective employer. Read about the benefits of Certification for an Individual and Employer.
Does Symantec End User Certification count toward Partner Program requirements and benefits?
End user certification does NOT count toward Partner Program requirements. To learn more view this FAQ sheet (PDF).
Is my Clearwell certification still valid?
See below for details to learn about the acquisition of Clearwell:
Customers
Partners
Is my PGP certification still valid?
See below for details to learn about the legacy acquisition of PGP:
Customers
Partners
Exams
How and where are the exams administered?
Are exams published on the same schedule worldwide?
How do I register and pay for a Symantec certification exam?
How much does it cost to take an exam?
What is the format of the exams?
How much time is allowed to take an exam?
How will I be notified that I have passed an exam?
How will Symantec be notified that I have passed an exam?
What score must I achieve to pass an exam?
Who sees my exam score(s)?
If I do not pass an exam, can I find out which questions I got wrong?
How many times can I take an exam, is there a waiting period, and is there a cost to retake an exam?
How can I find out what topics an exam will cover?
Are the exams based on current Symantec product versions?
How do I know what software release version an exam covers?
Are practice or sample exams available?
Why does Symantec list a range of questions for exams?
How are the exams developed?
How are passing scores established?
Certification
Training and Education
The exams are computer-based and delivered at Pearson VUE testing centers. Pearson VUE provides computer-based testing for information technology, academic, government and professional testing programs around the world. Pearson VUE provides a full suite of services from test development to data management, and delivers exams through the world’s most comprehensive and secure network of Test Center Locations in 175 countries. Pearson VUE is a business of Pearson (NYSE: PSO; LSE: PSON), the international media company, whose businesses include the Financial Times Group, Pearson Education and the Penguin Group.
Are exams published on the same schedule worldwide?
Exams will be available on the same schedule worldwide in English at Pearson VUE. Translations will be determined on a country-by-country basis.
How do I register and pay for a Symantec certification exam?
To register for a Symantec certification exam, login or create a Symantec CertTracker account. Exam fees are payable by credit card or by voucher. View the step-by-step instructions on how to register.
View the step-by-step instructions on how to purchase exam vouchers.
How much does it cost to take an exam?
The fee for a standard released Certification exam is $225 USD (or your country’s currency equivalent).
Symantec reserves the right to change exam fees at any time. Always check Pearson’s website to verify exams costs, schedules, and locations.
What is the format of the exams?
Exams are delivered in multiple-choice format, with each having approximately 65-100 questions. It’s common for the exams to contain exhibits/graphics. Exhibits/graphics are shown directly above the question.
How much time is allowed to take an exam?
Allotted exam time varies by exam length. It typically takes one minute to complete each exam question.
How will I be notified that I have passed an exam?
Pearson VUE provides you with instant results at the completion of your exam. A score report will be printed and given to you before you leave the testing center. Candidates are also able to view exam progress by logging into CertTracker.
How will Symantec be notified that I have passed an exam?
Symantec receives candidate exam results daily via file transfers from Pearson VUE to CertTracker Be sure you keep your personal information in your CertTracker profile up-to-date so that you receive proper credit for exams passed and certifications earned.
What score must I achieve to pass an exam?
Passing scores vary by exam. For more information on specific certifications in each category, please see the certification exam details within your selected product solution training path.
Who sees my exam score(s)?
You, Symantec, and your company (if you designate).
If I do not pass an exam, can I find out which questions I got wrong?
No. Symantec maintains this policy to ensure security over the exam questions.
How many times can I take an exam, is there a waiting period, and is there a cost to retake an exam?
If you do not pass an exam on your first attempt, you must wait at least 3 days (72 hours) before a second attempt. If you do not pass an exam on your second attempt, then you must wait at least 2 weeks (14 days) between each additional attempt. If you need to retake an exam that you have already passed in order to fulfill a certification track requirement, you may do so after 3 months. The same cost applies whether you take an exam once or many times.
How can I find out what topics an exam will cover?
Certification requirements, sample exams, exam objectives, recommended training and registration is available for each certification and corresponding exam. For more information on specific certifications in each category, please see the certification exam details within your selected product solution training path.
Are the exams based on current Symantec product versions?
Exams are developed for the current version of the Symantec product release at the time of development. Exams may be updated after significant new versions are released. New exams may not always correspond to the software release schedule.
How do I know what software release version an exam covers?
For more information on specific certifications in each category, please see the certification exam details within your selected product solution training path.
Are practice or sample exams available?
Sample exams are available. Each sample exam consists of multiple-choice items. Some items may have a supporting exhibit which you will be directed to view before answering the item. The sample exams are not timed, however, you should attempt to complete them as quickly as you can. Certification requirements, sample exams, exam objectives, study guides, recommended training, and registration is available for each certification and corresponding exam. For more information on specific certifications in each category, please see the certification exam details within your selected product solution training path.
Why does Symantec list a range of questions for exams?
Symantec regularly conducts statistical analyses of certification exam results for exam maintenance purposes. In doing so, Symantec publishes a range of questions per exam to account for “unscored” questions. In order to ensure the value of the Symantec certification program, Symantec routinely updates exams with new questions on an unannounced basis. Those new questions are initially delivered as “unscored” so that Symantec can evaluate the performance in the field/on the released exam. The “unscored” questions do not count towards your passing score and additional time is already incorporated into the total exam duration to answer these questions.
Symantec also regularly updates exam questions where the actual number of questions per exam may vary from time to time as these unannounced updates occur.
How are the exams developed?
Symantec end users, both internally and in the field, are studied to define the job performance requirements. The results determine the minimum level of competence required for the defined job performance and is tested in the exams. Symantec follows industry standards for “high stakes” exam development.
How are passing scores established?
Although it is intuitive to think that an appropriate passing score for an examination should be 70 or 75 percent correct based on personal experiences taking classroom tests, these arbitrary values may not reflect the performance level expected of the “minimally qualified candidate” given the difficulty of the test. For example, if the examination is very easy, a passing score of 70 may be too low. However, if the examination is very difficult, this same value may be too high.
Establishing passing scores requires the application of systematic procedures that consider the defined performance level definition of the “minimally qualified candidate” and the difficulty of the examination. Before the final passing scores are established, they are evaluated to ensure that the available validity evidence supports their use for the intended purpose of distinguishing the “minimally qualified candidates” from those who are not yet qualified. This systematic method is used to establish and maintain the fairness, validity and reliability of exams.
In order to ensure the value of the Symantec certification program, Symantec routinely updates exams with new questions. In these cases the passing percentage could change per exam from time to time as these unannounced updates occur
250-403 Administration of Symantec(TM)(R) Management Platform 7.1 Study Guide Prepared by Killexams.com Symantec Dumps Experts Exam Questions Updated On : Click To Check Update Killexams.com 250-403 Dumps | Real Questions 2019 100% Real Questions - Memorize Questions and Answers - 100% Guaranteed Success Free Download Link : https://killexams.com/demo-download/250-403.pdf 250-403 exam Dumps Source : Download 100% Free 250-403 Dumps PDF Test Code : 250-403 Test Name : Administration of Symantec(TM)(R) Management Platform 7.1 Vendor Name : Symantec Q&A : 174 Real Questions Read 250-403 dumps with real question to pass your exam We provide 250-403 exam questions with 100% pass guarantee. You have to practice questions for atleast 24 hours to obtain best scores in the exam. Your actual task to pass in 250-403 exam, begins with killexams.com 250-403 exam practice questions. All 250-403 dumps updated and validated on regular basis. If you are interested in just Passing the Symantec 250-403 exam to get a high paying job, you need to visit killexams.com and register to download full 250-403 question bank. There are several specialists working to collect 250-403 real exam questions at killexams.com. You will get Administration of Symantec(TM)(R) Management Platform 7.1 exam questions and VCE exam simulator to make sure you pass 250-403 exam. You will be able to download updated and valid 250-403 exam questions each time you login to your account. There are several companies out there, that offer 250-403 dumps but valid and updated 250-403 question bank is not free of cost. Think twice before you trust on Free 250-403 Dumps provided on internet. It require you to clear your concepts about all main concepts and objectives to Pass Symantec 250-403 exam. Just reading 250-403 course book is not sufficient. You need to learn about tricky scenarios and questions asked in real 250-403 exam. You need to go to killexams.com and download Free 250-403 PDF sample questions and read. If you feel that you can understand those 250-403 questions, you should register to download complete 250-403 question bank at very attractive discount coupons. That will be your first step toward success in Administration of Symantec(TM)(R) Management Platform 7.1 exam. Download and install 250-403 VCE exam simulator in your computer. Memorize 250-403 dumps and take practice test frequently with VCE exam simulator. When you feel that you are ready for real 250-403 exam, go to test center and register for actual test. You can copy 250-403 dumps PDF at any device line ipad, iphone, laptop, smart tv, android device to read and memorize the 250-403 braindumps while you are on vacation or travelling. This will save lot of your time, you will get more time to study 250-403 real questions. Practice 250-403 dumps with VCE exam simulator again and again until you get 100% marks. When you feel confident, straight go to test center for real 250-403 exam. Features of Killexams 250-403 dumps -> Instant 250-403 Dumps download Access -> Comprehensive 250-403 Questions and Answers -> 98% Success Rate of 250-403 Exam -> Guaranteed Real 250-403 exam Questions -> 250-403 Questions Updated on Regular basis. -> Valid 250-403 Exam Dumps -> 100% Portable 250-403 Exam Files -> Full featured 250-403 VCE Exam Simulator -> Unlimited 250-403 Exam Download Access -> Great Discount Coupons -> 100% Secured Download Account -> 100% Confidentiality Ensured -> 100% Success Guarantee -> 100% Free Dumps Questions for evaluation -> No Hidden Cost -> No Monthly Charges -> No Automatic Account Renewal -> 250-403 Exam Update Intimation by Email -> Free Technical Support Exam Detail at : https://killexams.com/pass4sure/exam-detail/250-403 Pricing Details at : https://killexams.com/exam-price-comparison/250-403 See Complete List : https://killexams.com/vendors-exam-list Discount Coupon on Full 250-403 Dumps Question Bank; WC2017: 60% Flat Discount on each exam PROF17: 10% Further Discount on Value Greatr than $69 DEAL17: 15% Further Discount on Value Greater than $99 250-403 Customer Reviews and Testimonials 250-403 exam prep had been given to be this smooth. HI, I had sign up for 250-403. Though I had study all chapters intensive, however your question bank supplied enough training. I passed this exam with 99 % the yesterday, Thanks lots for to the point question bank. Even my doubts were clarified in minimum time. I desire to use your carrier in future as correctly. You men are doing a top notch process. Thanks and Regards. Concerned for 250-403 exam? Get this 250-403 question . My friends told me I could count on killexams.com for 250-403 exam preparation, and this time I did. The brain dumps are very convenient to use, I love how they are set up. The question order helps you memorize things better. I passed with 89% marks. Passing the 250-403 exam with enough understanding. The Dumps provided with the help of the killexams.com became some thing Great. just 76% is sufficient for the exam, but I secured 92% marks within the real 250-403 exam. All credit score goes to you. tough to imagine that if I used every other product for my exam. Its tough to get an super product like this ever. thanks for the whole thing you supplied to me. I am able to sincerely recommend it to all. Got no trouble! three days schooling 250-403 real exam questions is required. In order to study and prepare for my 250-403 exam, I used killexams.com braindumps and exam simulator. All thanks to this incredibly astounding killexams.com. Thank you for assisting me in passing my 250-403 exam. Real 250-403 questions! I was not expecting such ease in exam. I handed 250-403 exam. I assume 250-403 certification is not given enough publicity and PR, given that its virtually well however seems to be below rated these days. That is why there arent many 250-403 braindumps with out price, so I had to buy this one. killexams.com package grew to turn out to be out to be as super as I expected, and it gave me precisely what I needed to recognise, no deceptive or wrong information. Awesome enjoy, excessive five to the team of builders. You men rock. Administration of Symantec(TM)(R) Management Platform 7.1 exam Whilst it is very hard task to choose reliable exam questions / answers resources regarding review, reputation and validity because people get ripoff due to choosing incorrect service. Killexams. com make it certain to provide its clients far better to their resources with respect to exam dumps update and validity. Most of other peoples ripoff report complaint clients come to us for the brain dumps and pass their exams enjoyably and easily. We never compromise on our review, reputation and quality because killexams review, killexams reputation and killexams client self confidence is important to all of us. Specially we manage killexams.com review, killexams.com reputation, killexams.com ripoff report complaint, killexams.com trust, killexams.com validity, killexams.com report and killexams.com scam. If perhaps you see any bogus report posted by our competitor with the name killexams ripoff report complaint internet, killexams.com ripoff report, killexams.com scam, killexams.com complaint or something like this, just keep in mind that there are always bad people damaging reputation of good services due to their benefits. There are a large number of satisfied customers that pass their exams using killexams.com brain dumps, killexams PDF questions, killexams practice questions, killexams exam simulator. Visit Killexams.com, our test questions and sample brain dumps, our exam simulator and you will definitely know that killexams.com is the best brain dumps site. COG-632 examcollection | 156-915 practice questions | GED questions and answers | HP0-621 sample test | SK0-004 exam questions | 000-896 practice exam | P2090-046 questions and answers | CUR-009 mock exam | 2B0-019 test prep | 650-322 brain dumps | HP2-E47 practice test | 70-743 Practice Test | 000-M97 free pdf | HP2-E50 real questions | PANRE VCE | C2040-442 braindumps | 000-376 test prep | A2040-404 practice questions | HP3-C11 study guide | BH0-010 real questions | 000-711 braindumps | 920-806 exam prep | 132-S-900.7 free pdf | LOT-801 free pdf download | NSE4_FGT-6-0 real questions | 9A0-066 questions answers | 117-102 practice test | ST0-079 real questions | HP2-T29 braindumps | C2090-632 sample test | VCS-276 practice exam | MD0-251 practice test | 000-656 dump | HP2-K10 Practice test | 1Z0-475 exam prep | 1Z0-853 brain dumps | PEGACSA72V1 study guide | CRNE questions and answers | 9A0-314 test prep | NSE5 pdf download | View Complete list of Killexams.com Brain dumps 000-874 practice questions | HP2-E28 questions answers | 1Z0-971 test prep | 1T6-510 cheat sheets | 70-486 dumps | 000-101 pdf download | 9L0-623 real questions | M9560-760 mock exam | HP2-K35 questions and answers | 000-M87 braindumps | PEGACBA001 braindumps | HP0-Y24 free pdf | HP2-061 brain dumps | 920-482 free pdf | EW0-100 study guide | 251-351 practice test | HP2-N57 questions and answers | 1Z0-950 Practice test | 1Y0-240 braindumps | HP0-Y52 examcollection | Administration of Symantec(TM)(R) Management Platform 7.1 test Prometic reports fourth quarter and 2018 year-end financial results | killexams.com 250-403 Real Questions and VCE Practice Test Total revenues for 2018 of $47.4 million compared to $39.1 million in 2017 Significant increase in bioseparation 2018 revenues to $22.7 million, a 35% increase over 2017 Net loss of $ 237.9 million for the year ended December 31, 2018 includes a non-cash writedown of intangible assets related to IVIG of $ 150.0 million Near-term financing shortfall requires urgent action to restructure the Corporation's indebtedness and raise capital LAVAL, QC, April 1, 2019 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic or the Corporation) reported today its financial results for the fourth quarter and year-ended December 31, 2018. 2018 Fourth Quarter and Year-End Financial Results RevenuesTotal revenues for the year ended December 31, 2018 were $47.4 million compared to $39.1 million during the comparative period of 2017, which represents an increase of $8.3 million. Total revenues for the quarter ended December 31, 2018 were $10.6 million compared to $6.6 million during the comparative period of 2017, representing an increase of $4.0 million. Revenues from the sale of goods were $45.6 million during the year ended December 31, 2018 compared to $16.5 million during the corresponding period of 2017, representing an increase of $29.1 million. The increased sales revenues for 2018 were mainly due to $22.8 million in sales of normal source plasma. The Corporation decided to sell this inventory as a result of the change in the production forecast due to the delay of the Biologics License Application ("BLA") approval for Ryplazim (plasminogen), ("RyplazimTM"). The remainder of the increase is mainly due to an increase in third party sales in the Bioseparations segment of $5.9 million. Revenues from the sale of goods were $10.3 million during the fourth quarter of 2018 compared to $5.5 million during the corresponding period of 2017, representing an increase of $4.8 million which was due to sales of $3.1 million of normal source plasma and an increase in third party bioseparations sales of $1.7 million. Cost of sales and other production expensesCost of sales and production were $38.0 million during the year ended December 31, 2018 compared to $10.1 million for the corresponding period in 2017, representing an increase of $27.9 million. Cost of sales and production for the quarter ended December 31, 2018 were $7.6 million compared to $2.4 million for the corresponding period in 2017, representing an increase of $5.2 million. The majority of the increase is due to the sales of normal source plasma in 2018 which overall was sold slightly below its carrying amount on a cumulative basis for the year but at a slight profit during the fourth quarter of 2018. The remainder of the increase in both periods is explained by the increase in products sold by the Bioseparations segment. Research and Development ("R&D")R&D expenses were $91.7 million during the year ended December 31, 2018 compared to $100.4 million for the corresponding period in 2017, representing a decrease of $8.7 million. R&D expenses were $21.1 million during the quarter ended December 31, 2018 compared to $28.2 million for the corresponding period in 2017, representing a decrease of $7.1 million. R&D expenses include the manufacturing cost of plasma-derived and small molecule therapeutics to be used in clinical trials and for the development of our production processes, with the majority of R&D expenses incurred in the plasma-derived therapeutics segment. The manufacturing cost of plasma-derived and small molecule therapeutics was $38.6 million during the year ended December 31, 2018 compared to $34.7 million during the year ended December 31, 2017, representing an increase of $3.9 million. The manufacturing cost of plasma-derived and small molecule therapeutics to be used in clinical trials and for the development of our production processes was $10.5 million during the three months ended December 31, 2018 compared to $10.9 million during the corresponding period of 2017, representing a decrease of $0.5 million. In 2018, there was a reduction in production activities at the Laval manufacturing plant while the facility focused on addressing the comments received by the U.S. Food and Drug Administration ("FDA") following their audit of this facility as part of the review of the BLA for RyplazimTM. This resulted in a reduction in overall manufacturing expenses for Plasma-derived therapeutics. However since there was no commercial production in 2018, none of these expenses were capitalized to inventories as compared to 2017. Other R&D expenses were $53.0 million during the year ended December 31, 2018 compared to $65.7 million for the corresponding period in 2017, representing a decrease of $12.6 million, and $10.7 million during the quarter ended December 31, 2018 compared to $17.3 million for the corresponding period in 2017, representing a decrease of $6.6 million. The decrease in the clinical trial and pre-clinical research expenses in both the small molecules and plasma-derived therapeutics segments were partially offset by additional spending in relation to the implementation and validation of additional analytical assays and "in-process" controls in the manufacturing of Ryplazim. Story continues Administration, Sales & MarketingAdministration, selling and marketing expenses were $31.5 million during the year ended December 31, 2018 compared to $31.4 million for the corresponding period in 2017, representing an increase of $0.1 million. The increase is mainly due to the increase in severance compensation which was partially offset by a decline in marketing expense. Administration, selling and marketing expenses were $10.7 million during the quarter ended December 31, 2018 compared to $8.8 million for the corresponding period in 2017, representing an increase of $1.9 million. The increase is mainly due to the increase in severance compensation. Finance CostsFinance costs were $22.1 million for the year ended December 31, 2018 compared to $8.0 million during the corresponding period of 2017, representing an increase of $14.1 million. Finance costs were $6.6 million for the quarter ended December 31, 2018 compared to $2.6 million during the corresponding period of 2017, representing an increase of $3.9 million. This increase reflects the higher level of debt during the year ended December 31, 2018 compared to the same period of 2017. Gain on extinguisment of LiabilitesOn November 14, 2018, the Corporation and Structured Alpha LP ("SALP"), an affiliate of Thomvest, modified the terms of the four loan agreements to extend, subject to compliance with covenants and debt servicing obligations, the maturity date of the non-revolving credit facility ("Credit Facility") from November 30, 2019 to September 30, 2024 and all three original issue discount notes from July 31, 2022 to September 30, 2024. The debt modification was accounted for as an extinguishment of the previous loans and the recording of new loans at their fair value determined as of the date of the modification, resulting in the recording of a gain on extinguishment of liabilities of $34.9 million Impairment losses on Intravenous Immunoglobulin ("IVIG") AssetsAs a result of various events affecting the Corporation during 2018, including; 1) the delay of the commercial launch of Ryplazim following the identification by the FDA of a number of changes required in the Chemistry, Manufacturing and Controls ("CMC") section of the BLA submission for congenital plasminogen deficiency, 2) the Corporation's limited financial resources since Q4 2018, which significantly delayed manufacturing expansion plans and resulted in the Corporation focusing its resources on refiling the RyplazimTM BLA as soon as possible; 3) the recognition of the larger than anticipated commercial opportunities for RyplazimTM, and 4) the change in executive leadership in Q4, the Corporation modified its strategic plans in Q4 to focus all available plasma-derived therapeutic segment resources on the manufacturing and development of RyplazimTM, for the treatment of congenital plasminogen deficiency and other indications. This, combined with the significant work determined to be required on the CMC section of an IVIG BLA, has caused the Corporation to suspend any new activities on IVIG. These changes and their various impacts prompted management to perform an impairment test of the intangible assets related to IVIG. Cash inflows beginning beyond 2023 were not considered in the calculation of the value in use impairment test due to the inherent uncertainty in forecasting cash flows beyond a five year period. As a result, Impairment losses totalling $150.0 million were recorded on these assets for the year and fourth quarter ended December 31, 2018. Net LossThe Corporation incurred a net loss of $237.9 million during the year ended December 31, 2018 compared to a net loss of $120.0 million for the corresponding period of 2017, representing an increase in the net loss of $117.9 million. The net loss in 2018 is higher mainly due to the non-cash impairment losses of $150.0 million related to IVIG, and the increase in finance cost of $14.1 million in the year ended December 31, 2018 compared to the corresponding period of 2017. This was partially offset by the recognition of a gain on extinguishments of liabilities of $33.6 million during the year ended December 31, 2018 compared to a loss on extinguishment of liabilities of $4.2 million for the corresponding period in 2017. Offsetting the increase in loss was the fact that no bad debt expense was recorded in 2018 while a $20.5 million expense was recorded in the previous year. The Corporation incurred a net loss of $141.3 million during the quarter ended December 31, 2018 compared to a net loss of $41.6 million for the corresponding period of 2017, representing an increase in net loss of $99.7 million. The increase was mainly affected by the impairment losses of $150.0 million related to IVIG recorded during the quarter ended December 31, 2018. This was partially offset by the recognition of a gain on extinguishment of liabilities of $33.6 million during the year ended December 31, 2018 compared to a loss on extinguishment of liabilities of $4.2 million for the corresponding period in 2017. Offsetting the increase in loss was the fact that no bad debt expense was recorded in 2018 while a $20.5 million expense was recorded during the fourth quarter of 2017. Commenting on the fourth quarter and 2018 year-end financial results, Bruce Pritchard, Prometic's Chief Operating Officer and Chief Financial Officer, said, "We have delivered on the financial guidance provided for 2018 with significantly reduced expenses and cash flows used in operating activities and increasing product sales. This allowed us to extend our cash runway into early 2019. We extended the repayment terms of our debt to 2024, subject to compliance with our covenants and debt service obligations, and implemented an at-the-market ("ATM") equity distribution program to help provide short term operating funds. We also retained the services of a global financial advisory and asset management firm to help us raise non-dilutive capital from partnerships and monetization of non-core assets. However, cash remains limited and we continue to rely on the support of SALP while working on these other initiatives." "Addressing our material liquidity and balance sheet challenges remains our highest priority. We anticipate that it will most likely require a combination of material corporate, financial and business development transactions to successfully stabilize the financial and liquidity position. This could include a restructuring of the SALP debt and / or recapitalization transaction, and a significant additional equity financing to finance the Corporation to value-creation catalysts such as partnerships and monetization of non-core assets " added Mr. Pritchard. Small Molecule Therapeutics Segment Key Events for 2018: PBI-4050 Published papers on the novel anti-fibrotic mechanism of action of its small molecule lead drug candidate, PBI-4050, in the American Journal of Pathology, in the Journal of Clinical Investigation and in the Journal of Pharmacology and Experimental Therapeutics PBI-4050 Disclosed new clinical data from the ongoing Alstrm Syndrome ("AS") phase 2 open label clinical trial being conducted in the U.K. demonstrating that the clinical activity and tolerability of PBI-4050 were sustained with prolonged treatment with further clinical activity in the heart and liver observed with longer treatment exposure PBI-4050 Received a Rare Pediatric Disease designation from the FDA for the treatment of AS 2019 Updates: Following the completion of the review and prioritization of all programs and assets, the main priorities for the small molecule therapeutics segment are: PBI-4050 The filing and approval of an Investigational New Drug application to enable the commencement of the pivotal phase 3 clinical study of PBI-4050 in AS during H2 2019. PBI-4050 - Prometic is planning a randomized, placebo-controlled phase 2 clinical study of PBI-4050 in patients with Nonalcoholic steatohepatitis ("NASH") to be initiated before the end of 2019 following successful financing PBI-4050 Prometic is planning a randomized, placebo-controlled, phase 2b clinical study of PBI-4050 in patients with idiopathic pulmonary fibrosis ("IPF") before the end of 2019 following successful financing. PBI-4547 Prometic is planning a phase 1 clinical study for its next small molecule compound, PBI-4547. This study is also expected to commence before the end of 2019 following successful financing. Plasma-Derived Therapeutics Segment Key Events for 2018: RyplazimTM Received a Complete Response Letter ("CRL") from the FDA arising from its review of the RyplazimTM BLA. The FDA identified the need for Prometic to make a number of changes in the Chemistry, Manufacturing and Controls ("CMC") portion of its BLA filing requiring the implementation and validation of additional analytical assays and "in-process controls" in the manufacturing process of Ryplazim. RyplazimTM Completed a Type C meeting with the FDA to discuss the Company's proposed action plan for the implementation of additional analytical assays and in-process controls related to the RyplazimTM manufacturing process. IVIG Presented new clinical data from the Corporation's pivotal phase 3 clinical study at the Clinical Immunology Society annual meeting in Toronto. The clinical data presented demonstrated comparable safety and efficacy data to existing commercial IVIG products without any significant drug related safety issues. Both clinical primary and secondary endpoints in adult patients suffering from primary immunodeficiencies were met and achieved. 2019 Updates: Following the completion of the review and prioritization of all programs and assets, the main priorities for the plasma-derived therapeutics segment are RyplazimTM The corporation expects to refile the BLA for Ryplazim during H2- 2019. After acceptance of the BLA, FDA would establish a new PDUFA date which the Corporation still believes would be eligible for a priority review. RyplazimTM The Corporation has determined that the best course of action would be to seek third party partners to assist in the commercialization of Ryplazim for all global markets, and discussions are currently ongoing to establish such arrangements. IVIG Prometic has now completed the required clinical package for IVIG required for a future BLA submission to the FDA. The completion of a robust CMC package for IVIG prior to filing a BLA still requires substantial work, time and investment. The Corporation needs to prioritize manufacturing capacity planning to meet the volume demands for RyplazimTM. IVIG and selected further proteins remain in our pipeline. However, the advanced stage of development and economics of RyplazimTM support a compelling case to focus all the available resources of the plasma-derived therapeutics segment on this therapeutic family to optimize its launch and growth. This, combined with the significant work determined to be required on the CMC section of an IVIG BLA, caused the Corporation to suspend any new activities on IVIG. This will result in a material delay to the commercialization of IVIG as compared to previous timelines and as such, $150.0 million of impairments on the assets pertaining to IVIG activiteswas recorded. Bioseparations Segment Key Events for 2018: External sales for 2018 exceeded $22.7 million, which represents a 35% increase over 2017. The Corporation anticipates moderate revenue growth for 2019 due to a number of factors including, the expansion of manufacturing activities by existing clients who utilize Prometic's products in their production processes, the adoption of products by new clients, and the introduction of new products in the bioseparation market. 2019 Update: The ongoing manufacturing expansion of the Isle of Man facility will enable the company to manufacture over 35,000 litres of chromatography adsorbents annually, with a potential sales value exceeding $133 million per annum. This additional manufacturing capacity will be used to meet the growing demand for the segment's products, and to provide the resins required for Prometic's own PPPSTM plasma protein manufacturing operations. Corporate and Operational Update Key Events for 2018: Subject to compliance with applicable covenants and servicing obligations, extended the maturity dates of its US$80 million (approx. $100 million) Credit Facility and original issue discount notes to September 2024 with SALP. Provided a corporate update related to a series of initiatives aiming at lengthening the cash runway to better position the Corporation to achieve its objectives. These included a significant reduction in the Corporation's cash used in operations for 2019, driven in part by growth in its bioseparation revenues and by a reduction of anticipated R&D expenditures by up to $30 million. Announced the closing of an ATM equity distribution agreement with Canaccord Genuity Corp. The ATM allows the Corporation, at its sole discretion and subject to conditions set forth in the equity distribution agreement, to issue small tranches of common shares from treasury, at prevailing prices and in appropriate market conditions. Named Prof. Simon Best as Interim Chief Executive Officer. Prof. Best has served as the Chairman of the Prometic Board of Directors since May 2014 and has over 30 years of global life sciences expertise with a focus on business development, strategic planning and product commercialization. Prof. Best succeeded Mr. Pierre Laurin who stepped down from his management and board responsibilities in December 2018. Subsequent Events to Fourth Quarter and 2018 Year-End Management and the Board of Directors are engaged in a comprehensive strategy to improve the financial and business conditions of the Corporation and, in January 2019, commenced a process to explore and evaluate potential strategic alternatives focused on maximizing shareholder value, including potential acquisitions, joint ventures, strategic alliances, or other merger and acquisition or capital markets transactions as well as any other transaction or alternative available to the Corporation. Concurrently, management and the Board of Directors have been actively exploring opportunities to bring forward cash flows to repay debt and fund working capital requirements. In conjunction with the strategic review and liquidity issues faced by the Corporation, in February 2019, the Board of Directors formed a special committee of independent directors to oversee the strategic review process (the "Special Committee"). The Special Committee meets regulary and oversees the work of management and the Corporation's financial and legal advisors in respect of such mandate. In February 2019, the Corporation engaged Lazard, a global financial advisory and asset management firm, to review and execute key strategic transactions focused on maximizing shareholder value. These transactions could include, among other things, the out-licensing of drug candidates and monetization of non-core assets.The Corporation has not set a timetable for this process, and there can be no assurance that a transaction will be entered into or consummated, or, if a transaction is undertaken, as to its terms, structure or timing. The Corporation does not expect to make further public comment regarding these matters unless and until the Board has approved a specific transaction or has concluded its review of strategic alternatives. In February and March 2019, the Corporation secured two additional tranches for a total of US$15.0 million from SALP under the existing Credit Facility. Concurrently, 19,401,832 warrants exercisable for Series A Preferred Shares of the Corporation with a term of eight years and an exercise price of $0.156 per warrant were issued on February 22, 2019. The Corporation drew US$10.0 million ($13.2 million) and US$5.0 million ($6.7 million) on February 22 and March 22 2019, respectively. During the first quarter of 2019, the Corporation issued 12,870,600 common shares under the ATM for total cash proceeds of $4.1 million. On March 31, 2019, Ms. Kory Sorenson resigned from Prometic's Board of Directors. Conference Call Information Prometic will host a conference call at 11:00 am (ET) on Tuesday April 2, 2019. The telephone numbers to access the conference call are (647) 427-7450 and 1-888-231-8191 (toll-free). A replay of the call will be available as of Tuesday April 2, 2019 at 2:00 pm. The numbers to access the replay are 1-416-849-0833 and 1-855-859-2056 (passcode:3198209). A live audio webcast of the conference call, with slides, will be available through the following : https://event.on24.com/wcc/r/1969851/0D5A0C85F48EBF7260AFC1BE9877F748 Additional Information in Respect to the Fourth Quarter and Year Ended December 31, 2018 Prometic's MD&A and 2018 consolidated financial statements for the quarter and year ended December 31, 2018 will be filed on SEDAR (http://www.sedar.com) and will be available on the Company's website at www.prometic.com. Prometic has decided to use the "notice-and-access" mechanism for delivery of its materials to its shareholders. Under the Notice-and-Access model, instead of receiving printed copies of Prometic's Audited Consolidated Financial Statements for the year ended December 31, 2018 and Management's Discussion and Analysis for the year-ended December 31, 2018 (collectively, the "Annual Report"), shareholders are invited to consult the Annual Report on Prometic's website at www.prometic.com under investors & media/investor briefcase, or on SEDAR's website. A copy of the Annual Report will also be available upon request, by telephone at 1-888-959-4007 or online at www.prometic.com/contactus. About Prometic Life Sciences Inc. Prometic (www.prometic.com) is a biopharmaceutical corporation with two drug discovery platforms focusing on unmet medical needs. The first platform (small molecule therapeutics) stems from the discovery of two receptors which we believe are at the core of how the body heals: namely, promoting tissue regeneration and scar resolution as opposed to fibrosis. One of the lead drug candidates emerging from this platform, PBI-4050, is expected to enter pivotal phase 3 clinical trials for the treatment of Alstrm syndrome. The second drug discovery and development platform (plasma-derived therapeutics) leverages Prometic's experience in bioseparation technologies used to isolate and purify biopharmaceuticals from human plasma. The Corporation's primary goal with respect to this second platform is to address unmet medical needs with therapeutic proteins not currently commercially available, such as Ryplazim.The Corporation also provides access to its proprietary bioseparation technologies to enable pharmaceutical companies in their production of non-competing biopharmaceuticals. Recognized as a bioseparations expert, the Corporation derives revenue from this activity through sales of affinity chromatography media which contributes to offset the costs of its own R&D investments. We are headquartered in Laval, Quebec (Canada) with R&D facilities in Canada, the United Kingdom and the United States, manufacturing facilities in Canada and the Isle of Man and corporate and business development activities in Canada, the United States, Europe and Asia. Forward Looking Statements This press release contains forward-looking statements about Prometic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, Prometic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of Prometic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations in Prometic's Annual Information Form for the year ended December 31, 2018, under the heading "Risk and Uncertainties related to Prometic's business". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations. All amounts are in Canadian dollars unless indicated otherwise. View original content:http://www.prnewswire.com/news-releases/prometic-reports-fourth-quarter-and-2018-year-end-financial-results-300822305.html 10-Q: QUICKLOGIC CORPORATION | killexams.com 250-403 Real Questions and VCE Practice Test (EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following Management's Discussion and Analysis of Financial Condition and Results of Operations, as well as information contained in "Risk Factors" in Part II, Item 1A and elsewhere in this Quarterly Report on Form 10-Q, contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend that these forward-looking statements be subject to the safe harbor created by those provisions. Forward-looking statements are generally written in the future tense and/or are preceded by words such as "will," "may," "should," "forecast," "could," "expect," "suggest," "believe," "anticipate," "intend," "plan," or other similar words. Forward-looking statements include statements regarding our strategies as well as (1) our revenue levels, including the commercial success of our Customer Specific Standard Products, or CSSPs, and new products, (2) the conversion of our design opportunities into revenue, (3) our liquidity, (4) our research and development efforts, (5) our gross profit and factors that affect gross profit, (6) our level of operating expenses, (7) our partners and suppliers and (8) industry trends. The following discussion should be read in conjunction with the attached condensed unaudited consolidated financial statements and notes thereto, and with our audited consolidated financial statements and notes thereto for the fiscal year ended December 30, 2012, found in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 8, 2013. Although we believe that the assumptions underlying the forward-looking statements contained in this Quarterly Report are reasonable, any of the assumptions could be inaccurate, and therefore there can be no assurance that such statements will be accurate. The risks, uncertainties and assumptions referred to above that could cause our results to differ materially from the results expressed or implied by such forward-looking statements include, but are not limited to, those discussed under the heading "Risk Factors" in Part II, Item 1A hereto and the risks, uncertainties and assumptions discussed from time to time in our other public filings and public announcements. All forward-looking statements included in this document are based on information available to us as of the date hereof. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that the results or conditions described in such statements or our objectives and plans will be achieved. Furthermore, past performance in operations and share price is not necessarily indicative of future performance. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Overview We develop and market low-power customizable semiconductor solutions that enable customers to add new differentiated features, extend battery life and improve the visual experience with their mobile, consumer and enterprise products. Our targeted mobile market segment includes Tablets, Smartphones and Mobile Enterprise. Our solutions typically fall into one of three product categories: Utilizing a focused customer engagement model, we market CSSPs to Original Equipment Manufacturers, or OEMs, and Original Design Manufacturers, or ODMs, that offer differentiated mobile products, and to processor vendors wishing to expand their served available market through the deployment of reference designs to their customers. Our solutions enable OEMs and ODMs to add new features, extend battery life and improve the visual experience of their handheld mobile devices. In addition to working directly with our customers, we partner with other companies with expertise in certain technologies to develop additional intellectual property, reference platforms and system software to provide application solutions. When we bring solutions to market with a partner company, we typically launch the solution as a Catalog CSSP. This enables us to sell the product as a 'catalog' device to any customer. In this manner, we are able to broaden the served available market for our CSSP solutions and leverage our R&D across multiple end customers. Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) We also work with mobile processor manufacturers in the development of reference designs or "Catalog" CSSPs. Through reference designs that incorporate our CSSPs, we believe mobile processor manufacturers can expand the served available market for their processors. Furthermore, should a CSSP development for a processor manufacturer be applicable to a set of common OEMs or ODMs, we can amortize our R&D investment over that set of OEMs/ODMs. We call this type of solution a Catalog CSSP. The first such Catalog CSSP was developed in conjunction with Texas Instruments Incorporated, and introduced to the market during the second half of 2012. We are placing a greater emphasis on developing and marketing Catalog CSSPs in the future. In order to grow our revenue from its current level, we depend upon increased revenue from our new products including existing new product platforms and platforms currently in development. We expect our business growth to be driven by CSSPs and our CSSP revenue growth needs to be strong enough to enable us to sustain profitability while we continue to invest in the development, sales and marketing of our new solution platforms, PSBs and CSSPs. The gross margin associated with our CSSPs is generally lower than the gross margin of our FPGA products, due primarily to the price sensitive nature of the higher volume mobile consumer opportunities that we are pursuing with CSSPs. During the third quarter of 2013, we generated total revenue of $9.1 million which represents an increase of 77% over the prior quarter and an increase of 148% from the third quarter of 2012. Our new product revenue increased to $7.1 million, up 131% sequentially and up 358% year over year. The increase in new product revenue was primarily due to shipments of our ArcticLink III solution platform to Samsung. Revenue generated from Samsung accounted for 86% of our new product revenue and 68% of our total revenue. During the quarter, new products were shipped into the Tablet, Smartphone and the Mobile Enterprise markets. Our mature product revenue was $1.9 million, down 5% sequentially and down 8% year over year. Since we introduced CSSPs to the market in early 2007, we have devoted substantially all of our development, sales and marketing efforts on our new solution platforms, PSBs and CSSPs. We expect our revenue from mature products to continue to decline over time. Overall, we reported a net loss of $2.3 million for the third quarter of 2013. Critical Accounting Estimates The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our consolidated financial statements. The SEC has defined critical accounting policies as those that are most important to the portrayal of our financial condition and results of operations and require us to make difficult and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our critical policies include revenue recognition, valuation of inventories including identification of excess quantities and product obsolescence, valuation of investments, valuation of long-lived assets, measurement of stock-based compensation and estimating accrued liabilities. We believe that we apply judgments and estimates in a consistent manner and that this consistent application results in consolidated financial statements and accompanying notes that fairly represent all periods presented. However, any factual errors or errors in these judgments and estimates may have a material impact on our financial statements. For a discussion of critical accounting policies and estimates, please see Item 7 in our Annual Report on Form 10-K for the fiscal year ended December 30, 2012, filed with the SEC on March 8, 2013. Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) Results of Operations The following table sets forth the percentage of revenue for certain items in our statements of operations for the periods indicated: Three Months Ended September 29, September 30, 2013 2012 Revenue 100.0 % 100.0 % Cost of revenue 66.6 % 52.4 % Gross profit 33.4 % 47.6 % Operating expenses: Research and development 22.6 % 51.0 % Selling, general and administrative 35.4 % 72.7 % Restructuring costs (0.4 )% - % Income (loss) from operations (24.2 )% (76.1 )% Interest expense (0.1 )% (0.3 )% Interest income and other expense, net (0.8 )% 0.5 % Income (loss) before income taxes (25.1 )% (75.9 )% Provision for (benefit from) income taxes (0.2 )% 0.6 % Net Income (loss) (24.9 )% (76.5 )% Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) Three Months Ended September 29, 2013 and September 30, 2012 Revenue The table below sets forth the changes in revenue for the three months ended September 29, 2013, as compared to the three months ended September 30, 2012 (in thousands, except percentage data): Three Months Ended September 29, 2013 September 30, 2012 Change % of Total % of Total Amount Revenues Amount Revenues Amount Percentage Revenue by product line (1): New products $ 7,139 79 % $ 1,558 43 % $ 5,581 358 % Mature products 1,927 21 % 2,099 57 % (172 ) (8 )% Total revenue $ 9,066 100 % $ 3,657 100 % $ 5,409 148 % _ (1) For all periods presented: New products represent products introduced since 2005, and include ArcticLink(R), ArcticLink II, ArcticLink III, Eclipse(TM) II, PolarPro(R), PolarPro II, and QuickPCI II. Mature products include Eclipse, EclipsePlus, pASIC(R) 1, pASIC 2, pASIC 3, QuickFC, QuickMIPS, QuickPCI, QuickRAM, and V3, as well as royalty revenue, programming hardware and software. The increase in new product revenue was primarily due to shipments to Samsung which has designed our ArcticLink III VX into a new tablet platform. Revenue generated from Samsung accounted for 86% of the new product revenue and 68% of total revenue in the third quarter of 2013. The decrease in mature product revenue is due primarily to reduced orders from our customers in the aerospace, test and instrumentation sectors. We continue to seek to expand our revenue through the pursuit of high volume sales opportunities in our target market segments and the sale of CSSPs incorporating our PSBs. Our industry is characterized by intense price competition and by lower margins as order volumes increase. While winning large-volume sales opportunities will increase our revenue, due to the pricing negotiation leverage of large companies, these opportunities may decrease our gross profit as a percentage of revenue. Gross Profit The table below sets forth the changes in gross profit for the three months ended September 29, 2013 as compared to the three months ended September 30, 2012 (in thousands, except percentage data): Three Months Ended September 29, 2013 September 30, 2012 Change % of Total % of Total Amount Revenues Amount Revenues Amount Percentage Revenue $ 9,066 100 % $ 3,657 100 % $ 5,409 148 % Cost of revenue 6,037 67 % 1,916 52 % 4,121 215 % Gross Profit $ 3,029 33 % $ 1,741 48 % $ 1,288 74 % The $1.3 million increase in gross profit in the third quarter of 2013 as compared to the third quarter of 2012 was mainly due to the increase in revenue, partially offset by the increase in inventory reserve of $130,000 and the increase in royalties of $231,000 in the third quarter of 2013. The decline in the gross margin percentage is due to the large concentration of our revenue from Samsung in the tablet market segment which is characterized by intense price competition and lower margins. Our semiconductor products have historically had long product life cycles and obsolescence has not been a significant factor in the valuation of inventories. However, as we pursue opportunities in the mobile market and continue to develop new CSSPs and products, we believe our product life cycle will be shorter and increase the potential for obsolescence. We also regularly review the cost of inventories against estimated market value and record a lower of cost or market reserve for inventories that have a cost in excess of estimated market value. This could have a material impact on our gross margin and Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) inventory balances based on additional write-downs to net realizable value or a benefit from inventories previously written down. Operating Expenses The table below sets forth the changes in operating expenses for the three months ended September 29, 2013, as compared to the three months ended September 30, 2012 (in thousands, except percentage data): Three Months Ended September 29, 2013 September 30, 2012 Change % of Total % of Total Amount Revenues Amount Revenues Amount Percentage R&D expense $ 2,052 23 % $ 1,865 51 % $ 187 10 % SG&A expense 3,207 35 % 2,658 73 % 549 21 % Restructuring credits (32 ) - % - - % (32 ) - % Total operating expenses $ 5,227 58 % $ 4,523 124 % $ 704 16 % Research and Development Our research and development, or R&D, expenses consist primarily of personnel, overhead and other costs associated with engineering process improvements, programmable logic design, CSSP design and software development. The $187,000 increase in R&D expenses in the third quarter of 2013, as compared to the third quarter of 2012, was attributable primarily to a $217,000 increase in equipment and supplies and a $70,000 increase in compensation expenses. These expenses were partially offset by a $98,000 decrease in third party chip design costs. Selling, General and Administrative Expense Our selling, general and administrative, or SG&A, expenses consist primarily of personnel and related overhead costs for sales, marketing, finance, administration, human resources and general management. The $549,000 increase in SG&A expenses in the third quarter of 2013, as compared to the third quarter of 2012, was primarily due to a $472,000 increase in compensation expenses due to increased headcount and accrued executive bonuses; a $140,000 increase in outside services related to sales commissions; and a $140,000 increase in occupancy costs. These expenses were partially offset by a $153,000 decrease in stock-based compensation expenses. Restructuring Costs In an effort to consolidate and streamline its engineering organization, the Company implemented a restructuring plan on March 28, 2013. The net charges for employee severance benefits under this restructuring plan was $181,000 as of September 29, 2013. Interest Expense and Interest Income and Other Expense, Net The table below sets forth the changes in interest expense and interest income and other, net, for the three months ended September 29, 2013 as compared to the three months ended September 30, 2012 (in thousands, except percentage data): Three Months Ended Change September 29, September 30, 2013 2012 Amount Percentage Interest expense $ (8 ) $ (12 ) $ 4 (33 )% Interest income and other expense, net (74 ) 18 (92 ) (511 )% $ (82 ) $ 6 $ (88 ) (1467 )% The decrease in interest expense was due primarily to the reduction in interest accrued for leased design software tools in the third quarter of 2013 as compared to the third quarter of 2012. The change in interest income and other expense, net, was due primarily to foreign exchange fluctuations in the third quarter of 2013 as compared to the third quarter of 2012. Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) We conduct a portion of our research and development activities in Canada and India and we have sales and marketing activities in various countries outside of the United States. Most of these international expenses are incurred in local currency. Foreign currency transaction gains and losses are included in interest and other income (expense), net, as they occur. We do not use derivative financial instruments to hedge our exposure to fluctuations in foreign currency and, therefore, our results of operations are, and will continue to be, susceptible to fluctuations in foreign exchange gains or losses. Provision for (Benefit from) Income Taxes The table below sets forth the changes in provision for income taxes for the three months ended September 29, 2013 as compared to the three months ended September 30, 2012 (in thousands, except percentage data): Three Months Ended Change September 29, September 30, 2013 2012 Amount Percentage Provision for (Benefit from) income taxes $ (18 ) $ 22 $ (40 ) (182 )% The income tax benefit for the third quarter of 2013 resulted from a reversal of a foreign tax accrual. The income tax provision for the third quarter of 2012 was primarily from our foreign operations which are cost-plus entities. As of the end of the third quarter of 2013, our ability to utilize our income tax loss carryforwards in future periods is uncertain and, accordingly, we recorded a full valuation allowance against the related U.S. tax provision. We will continue to assess the realizability of deferred tax assets in future periods. Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) Nine Months Ended September 29, 2013 and September 30, 2012 Revenue The table below sets forth the changes in revenue for the nine months ended September 29, 2013 as compared to the nine months ended September 30, 2012 (in thousands, except percentage data): Nine Months Ended September 29, 2013 September 30, 2012 Change % of Total % of Total Amount Revenues Amount Revenues Amount Percentage Revenue by product line (1): New products $ 11,174 65 % $ 4,915 41 % $ 6,259 127 % Mature products 6,035 35 % 6,943 59 % (908 ) (13 )% Total revenue $ 17,209 100 % $ 11,858 100 % $ 5,351 45 % (1) For all periods presented: New products represent products introduced since 2005, and include ArcticLink(R), ArcticLink II, ArcticLink III, Eclipse(TM) II, PolarPro(R), PolarPro II, and QuickPCI II. Mature products include Eclipse, EclipsePlus, pASIC(R) 1, pASIC 2, pASIC 3, QuickFC, QuickMIPS, QuickPCI, QuickRAM, and V3, as well as royalty revenue, programming hardware and software. The increase in new product revenue was primarily driven by shipments of our ArcticLink III VX device to Samsung. Revenue generated from Samsung accounted for 76% of the new product revenue and 49% of the total revenue. The decrease in mature product revenue is due primarily to low bookings from our customers in the aerospace, test and instrumentation sectors. We continue to seek to expand our revenue through the pursuit of high-volume sales opportunities in the consumer market segment and the sale of CSSPs incorporating our PSBs. Our industry is characterized by intense price competition and by lower margins as order volumes increase. While winning large-volume sales opportunities will increase our revenue, we believe these opportunities may decrease our gross profit as a percentage of revenue. Gross Profit The table below sets forth the changes in gross profit for the nine months ended September 29, 2013 as compared to the nine months ended September 30, 2012 (in thousands, except percentage data): Nine Months Ended September 29, 2013 September 30, 2012 Change % of Total % of Total Amount Revenues Amount Revenues Amount Percentage Revenue $ 17,209 100 % $ 11,858 100 % $ 5,351 45 % Cost of revenue 11,210 65 % 6,313 53 % 4,897 78 % Gross Profit $ 5,999 35 % $ 5,545 47 % $ 454 8 % The $454,000 increase in gross profit in the first nine months of 2013 as compared to the first nine months of 2012 was mainly due to the increase in revenue, partially offset by the increase in royalty accruals of $278,000 in the first nine months of 2013. The decline in the gross margin percentage is due to the large concentration of our revenue from Samsung in the tablet market segment which is characterized by intense price competition and lower margins. Operating Expenses Table of Contents Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Continued) The table below sets forth the changes in operating expenses for the nine months ended September 29, 2013 as compared to the nine months ended September 30, 2012 (in thousands, except percentage data): Nine Months Ended September 29, 2013 September 30, 2012 Change % of Total % of Total Amount Revenues Amount Revenues Amount Percentage R&D expense $ 5,902 34 % $ 7,119 60 % $ (1,217 ) (17 )% . . . Nov 05, 2013 (c) 1995-2013 Cybernet Data Systems, Inc. All Rights Reserved Spirent Communications' (SPMYY) CEO Eric Hutchinson on Q2 2017 Results - Earnings Call Transcript | killexams.com 250-403 Real Questions and VCE Practice Test No result found, try new keyword!In Lifecycle Service Assurance, the reduction in lab test pending ahead of the shift into live ... to support new product launches and further develop our key account management. Administration costs ... Direct Download of over 5500 Certification Exams References : Dropmark : http://killexams.dropmark.com/367904/11889542 Wordpress : http://wp.me/p7SJ6L-22o Dropmark-Text : http://killexams.dropmark.com/367904/12875363 Blogspot : http://killexamsbraindump.blogspot.com/2017/12/symantec-250-403-dumps-and-practice.html RSS Feed : http://feeds.feedburner.com/WhereCanIGetHelpToPass250-403Exam Box.net : v


250-403 Free PDF Download

References:


Free Download 250-403 PDF Dumps
Free Download Killexams Certification Exam Dumps
Killexams Certification Exam Questions and Answers - amongtheway
Killexams Exam Study Notes, study guides - www.amongtheway.com
Killexams Certification Exam Questions and Answers - st.edu
Killexams Exam Study Notes, study guides - st.edu
Killexams Certification Exam Questions and Answers - Puntotecnia
Killexams Exam Study Notes, study guides - Puntotecnia
Killexams Certification Exam Questions and Answers
Killexams Exam Study Notes, study guides
Killexams Certification Exam Questions and Answers and Study Notes
Killexams Exam Study Notes, study guides, QA
Killexams Exam Study Notes
Killexams Certification Exam Study Notes
Killexams Certification Exam Study Notes
Killexams Certification Exam Study Notes
Download Hottest Killexams Certification Exams - CSCPK
Here you will find Real Exam Questions and Answers of every exam - dinhvihaiphong.net
Study notes to cover complete exam syllabus - Killexams.com
Killexams Exams Download Links - nrnireland.org
Killexams Study Guides and Exam Simulator - simepe.com.br
Killexams Study Guides and Exam Simulator - skinlove.nl
Killexams Study Guides and Exam Simulator - marinedubai.com/


www.pass4surez.com (c) 2017-2021